Streptococcal septicaemia

AB1_STREPTO_SEPSIS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — A40 Hospital discharge: ICD-9 — 038[0] Hospital discharge: ICD-8 — 038[0] Cause of death: ICD-10 — A40 Cause of death: ICD-9 — 038[0] Cause of death: ICD-8 — 038[0] 2 out of 7 registries used, show all original rules.	3798
4. Check minimum number of events None	3798
5. Include endpoints None	3798
6. Filter based on genotype QC (FinnGen only)	3657

Control definitions (FinnGen only)

Control exclude: AB1_OTHER_BACTERIAL

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF5

NAME	AB1_STREPTO_SEPSIS
CONTROL_EXCLUDE	AB1_OTHER_BACTERIAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A40
HD_ICD_9	038[0]
HD_ICD_8	038[0]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	A40
COD_ICD_9	038[0]
COD_ICD_8	038[0]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Streptococcal septicaemia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	30449	13253	16974
Only index persons	24844	10973	13871
Unadjusted period prevalence (%)
Whole population	0.43	0.38	0.47
Only index persons	0.47	0.40	0.53
Median age at first event (years)
Whole population	60.80	62.34	59.49
Only index persons	60.39	61.75	59.32

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3657	1501	2156
Unadjusted period prevalence (%)	0.80	0.53	0.99
Median age at first event (years)	65.81	62.55	68.09

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3798: Matched controls
37980

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.1

320.6

1194

3858

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

6.1

317.3

619

1181

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

11.1

307.7

368

362

R50.9

ICD-10 Finland

Fever, unspecified

6.2

307.7

1184

2579

A49.9

ICD-10 Finland

Bacterial infection, unspecified

105.4

307.7

1176

161

A40.9

ICD-10 Finland

Streptococcal sepsis, unspecified

+∞

307.7

431

A40.1

ICD-10 Finland

Sepsis due to streptococcus, group B

+∞

307.7

354

A40.8

ICD-10 Finland

Other streptococcal sepsis

16384.0

307.7

1417

C03CA01

ATC

furosemide; systemic

3.9

307.7

1900

7832

A41.9

ICD-10 Finland

Sepsis, unspecified

686.3

307.7

677

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

80.1

307.7

212

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

7.0

307.7

555

909

A41.8

ICD-10 Finland

Other specified sepsis

955.7

307.7

348

A40.0

ICD-10 Finland

Sepsis due to streptococcus, group A

+∞

307.7

502

A46

ICD-10 Finland

Erysipelas

21.4

307.7

1386

995

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.8

307.7

2463

12341

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

81.2

307.7

495

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.1

307.7

1328

3649

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

324.5

307.7

299

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

16206.0

307.7

1151

J18.9

ICD-10 Finland

Pneumonia, unspecified

5.2

307.7

1890

6064

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

7.8

286.6

421

596

S97

ICPC

Chronic ulcer skin

6.6

286.5

500

852

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

21.2

278.5

211

105

J01MA12

ATC

levofloxacin; systemic

3.8

275.6

1117

3780

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.7

268.4

727

1832

TPH04

NOMESCO Finland

Cathetrisation of vein

3.5

257.4

1250

4727

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

4.6

252.0

698

1785

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.0

243.6

821

2427

TK800

NOMESCO Finland

Hemodialysis

13.1

243.0

237

192

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

1200.0

233.7

226

J01FF01

ATC

clindamycin; systemic

3.1

228.9

1352

5687

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

9.7

212.8

256

282

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

10.2

211.4

244

254

I50.9

ICD-10 Finland

Heart failure, unspecified

3.5

210.5

925

3239

JN4AD

NOMESCO Finland

Body CT examination

4.2

210.2

644

1765

SPAT1255

SPAT

Intravenous administration of medicine

5.1

205.6

468

1012

N17.9

ICD-10 Finland

Acute renal failure, unspecified

6.6

196.4

333

546

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

10.2

191.9

221

229

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.9

190.4

657

1952

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

9.7

179.7

214

232

J01CE08

ATC

benzathine benzylpenicillin; parenteral

214.8

178.8

184

Z49.1

ICD-10 Finland

Extracorporeal dialysis

16.3

177.8

152

I50.0

ICD-10 Finland

Congestive heart failure

4.1

176.4

540

1470

ZXD05

NOMESCO Finland

Urgent procedure

2.7

176.3

1458

7156

TPH07

NOMESCO Finland

Cathetrisation of artery

3.5

175.8

699

2276

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.9

174.4

1056

4406

WW500

NOMESCO Finland

Blood transfusion

6.5

172.1

292

478

JN4BD

NOMESCO Finland

Extensive body CT

3.7

168.6

614

1884

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.4

166.6

699

2350

B01AA03

ATC

warfarin; systemic

2.8

163.9

1138

5083

WX872

NOMESCO Finland

Intensive care

4.8

163.0

394

891

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.2

161.1

747

2666

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

4.3

159.4

444

1123

WX892

NOMESCO Finland

Monitored bed care

4.0

157.4

505

1417

S76

ICPC

Skin infection other

5.2

157.2

342

707

127

Kela drug reimbursment

Transplant complication

13.1

154.4

149

118

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.6

154.2

1227

5840

J01MA14

ATC

moxifloxacin; systemic

3.8

149.6

519

1535

B01AB05

ATC

enoxaparin; parenteral

2.5

149.0

1435

7451

M46.4

ICD-10 Finland

Discitis, unspecified

50.5

145.5

N02AA05

ATC

oxycodone; systemic

2.8

144.7

903

3785

NHQ40

NOMESCO Finland

Amputation of toe

12.3

144.7

145

122

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

14.0

144.6

134

B03XA02

ATC

darbepoetin alfa; parenteral

9.2

142.9

176

199

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

24.7

142.7

101

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

7.3

139.9

212

307

TPX10

NOMESCO Finland

Implantation of vascular injection port

7.6

139.9

204

283

TQW11

NOMESCO Finland

Vacuum treatment of wound

9.2

138.4

171

194

M04AA01

ATC

allopurinol; systemic

2.9

133.6

747

2941

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.4

131.0

1205

6061

ZX120

NOMESCO Finland

Intravenous

3.4

129.1

511

1641

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

16.8

128.9

108

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

7.4

127.4

189

267

C03DA01

ATC

spironolactone; oral

3.0

125.0

657

2494

N18.0

ICD-10 Finland

End-stage renal disease

15.3

124.1

109

WX408

NOMESCO Finland

General anesthesy, balanced

2.4

123.9

1182

6019

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.3

122.8

531

1799

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

4.2

122.0

352

909

L04AA06

ATC

mycophenolic acid; systemic

9.4

120.4

145

159

R4110

NOMESCO Finland

Physiotherapy

2.3

119.4

1246

6578

A11CC03

ATC

alfacalcidol; systemic

7.1

119.4

183

268

JN3AD

NOMESCO Finland

Abdominal CT examination

3.1

119.3

567

2029

D64.9

ICD-10 Finland

Anaemia, unspecified

3.0

118.9

602

2234

N18.8

ICD-10 Finland

Other chronic renal failure

6.4

118.4

202

331

A10AB05

ATC

insulin aspart; parenteral

3.6

117.9

434

1327

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

10.4

117.0

131

130

TK810

NOMESCO Finland

Hemofiltration

22.9

116.6

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

7.7

115.2

164

221

A12AA04

ATC

calcium carbonate; oral

9.8

115.0

135

143

AA1AD

NOMESCO Finland

CT of head and brain

2.3

114.0

1268

6852

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.4

113.7

458

1482

XW000

NOMESCO Finland

Bone marrow biopsy

4.6

112.1

277

634

J01DB01

ATC

cefalexin; oral

2.7

111.6

3180

24970

XF400

NOMESCO Finland

ECG with 12 standard connections

2.6

111.4

816

3658

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

6.4

111.1

190

312

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

25.8

109.2

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.7

108.3

363

1041

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

28.2

106.7

ZZA00

NOMESCO Finland

Split skin graft

5.6

105.5

207

388

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

7.6

105.3

152

208

A10AE04

ATC

insulin glargine; parenteral

3.0

104.7

507

1827

196

Kela drug reimbursment

Paricalcitol and cinacalcet

38.3

103.9

A28

ICPC

Limited function/disability NOS

2.4

103.8

853

4020

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.4

103.1

276

672

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.5

101.1

764

3460

L89

ICD-10 Finland

Decubitus ulcer and pressure area

7.8

100.7

142

189

R60.0

ICD-10 Finland

Localized oedema

2.8

100.5

585

2328

B99

ICD-10 Finland

Other and unspecified infectious diseases

7.7

100.3

142

190

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

100.3

1261

7090

J86.9

ICD-10 Finland

Pyothorax without fistula

11.1

99.3

106

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

16.7

97.9

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.6

97.1

237

536

J01CF05

ATC

flucloxacillin; systemic

3.8

97.1

310

858

L03AA02

ATC

filgrastim; parenteral

6.0

96.9

175

303

H02AB06

ATC

prednisolone; systemic

2.0

96.1

1873

12331

Z94.0

ICD-10 Finland

Kidney transplant status

12.9

95.9

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.4

94.9

368

1158

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

5.5

94.6

189

360

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.3

94.1

394

1300

ZXE20

NOMESCO Finland

More than three and less than five hours

2.6

93.9

657

2861

Z3226

NOMESCO Finland

Physiotherapist

2.4

93.8

829

4015

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

4.2

91.5

259

657

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.0

89.9

1959

13301

C07AB07

ATC

bisoprolol; oral

2.0

89.6

2067

14304

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

12.5

89.1

Z3231

NOMESCO Finland

Registered nurse

2.1

89.0

1192

6807

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.8

88.8

489

1883

V03AE01

ATC

polystyrene sulfonate; oral

8.8

88.0

111

129

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

87.7

1612

10298

V03AE02

ATC

sevelamer; oral

25.8

87.7

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

7.5

86.5

125

171

GD1AD

NOMESCO Finland

Thorax CT examination

3.5

86.5

317

961

L04AD01

ATC

ciclosporin; systemic

7.6

86.2

123

166

WX882

NOMESCO Finland

High dependency care

5.0

85.6

189

393

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

5.0

84.6

187

389

Z2446

NOMESCO Finland

Social worker

3.4

84.5

332

1052

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

82.6

1299

7822

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.1

82.1

384

1349

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

10.0

82.1

J01MA02

ATC

ciprofloxacin; systemic

1.9

81.8

1574

10147

QDA10

NOMESCO Finland

Incision of skin of lower limb

14.2

81.0

ZXE00

NOMESCO Finland

One hour or less

1.9

80.4

1533

9836

I38

ICD-10 Finland

Endocarditis, valve unspecified

47.6

80.2

B01AB10

ATC

tinzaparin; parenteral

2.8

80.0

447

1731

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.9

79.6

248

673

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.8

79.5

452

1766

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.8

79.3

250

684

M10.9

ICD-10 Finland

Gout, unspecified

3.1

79.1

363

1261

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.6

79.0

271

786

A07AA09

ATC

vancomycin; oral

9.0

78.7

112

C90.0

ICD-10 Finland

Multiple myeloma

8.2

78.1

105

132

WW200

NOMESCO Finland

Immunization

5.1

78.1

170

349

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.4

77.7

628

2904

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

13.8

77.6

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.9

77.1

176

376

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.9

77.1

389

1425

N17.8

ICD-10 Finland

Other acute renal failure

8.7

77.1

115

SPAT1262

SPAT

Handing over of treatment supplies

2.2

76.9

790

4040

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.9

76.8

236

634

M46.3

ICD-10 Finland

Infection of intervertebral disc (pyogenic)

119.7

76.2

WZC00

NOMESCO Finland

Treatment plan or consultation

1.9

75.9

1395

8800

SPAT1254

SPAT

Administration of medicine

2.3

75.9

679

3278

A10AC01

ATC

insulin (human); parenteral

2.9

74.9

374

1361

Z49.0

ICD-10 Finland

Preparatory care for dialysis

11.0

74.8

A02BC02

ATC

pantoprazole; systemic

1.9

74.8

2545

19512

B18.2

ICD-10 Finland

Chronic viral hepatitis C

10.2

74.5

J01XX08

ATC

linezolid; systemic

16.6

73.7

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

19.0

73.6

R06.0

ICD-10 Finland

Dyspnoea

2.0

73.4

1106

6508

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

7.2

73.3

110

157

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.3

72.9

298

965

N02AX02

ATC

tramadol; systemic, rectal

1.9

72.7

1668

11258

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

5.8

72.6

135

240

WX213

NOMESCO Finland

Lower leg blockade

13.2

72.5

WX730

NOMESCO Finland

Conventional respirator

6.5

72.5

119

187

137

Kela drug reimbursment

Uraemia requiring dialysis

11.2

72.0

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

364.1

71.9

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.9

71.2

364

1341

TKC20

NOMESCO Finland

Catheterisation of bladder

2.9

71.1

370

1376

D70.82

ICD-10 Finland

Drug-induced neutropenia

9.5

70.8

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.3

70.7

290

941

J01CA04

ATC

amoxicillin; systemic

2.1

70.0

3004

24592

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.4

69.9

260

794

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

69.7

1045

6121

H02AB02

ATC

dexamethasone; systemic

2.6

69.5

456

1909

H05BX01

ATC

cinacalcet; oral

15.6

69.2

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.5

69.1

504

2217

207

Kela drug reimbursment

Chronic arrhythmias

2.1

68.1

758

3981

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.3

68.1

270

858

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

4.0

66.7

197

514

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

66.6

321

1144

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

66.5

693

3544

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

14.5

66.5

L04AD02

ATC

tacrolimus; systemic

10.0

65.8

Z2221

NOMESCO Finland

Medical doctor

1.9

65.4

1061

6360

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

3.4

64.5

240

732

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

22.6

64.2

C01AA05

ATC

digoxin; systemic

2.5

64.2

429

1809

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

3.2

63.6

265

867

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

63.4

1137

7031

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.3

62.6

553

2640

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

62.4

1382

9113

A03

ICPC

Fever

2.2

62.1

617

3089

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.7

61.9

364

1440

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

8.7

61.6

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

6.8

61.5

146

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.5

61.4

447

1959

N03AX16

ATC

[U] pregabalin

2.0

61.4

886

5091

J04AB02

ATC

rifampicin; systemic

8.3

60.8

A03FA01

ATC

metoclopramide; systemic, rectal

2.0

60.6

798

4438

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

6.8

60.3

143

S18

ICPC

Laceration/cut

1.7

59.9

1756

12519

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.8

59.7

328

1252

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

59.5

762

4193

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.9

59.4

997

6013

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.5

59.3

411

1760

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

59.2

758

4170

SPAT1263

SPAT

Sampling

1.8

58.9

1556

10755

WX002

NOMESCO Finland

Sedation and analgesia

2.0

58.9

792

4433

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

13.6

58.8

153

Kela drug reimbursment

Lenalidomid

11.5

58.7

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.6

58.7

200

576

L28

ICPC

Limited function/disability (L)

2.0

58.5

732

3992

A40.2

ICD-10 Finland

Sepsis due to streptococcus, group D and enterococcus

+∞

58.5

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

6.2

58.4

100

164

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

57.8

646

3378

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

11.7

57.6

X59

ICD-10 Finland

Exposure to unspecified factor

2.0

57.6

741

4079

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

6.5

57.5

147

ZX108

NOMESCO Finland

Inhalation

12.0

57.5

V03AE03

ATC

lanthanum carbonate; oral

25.3

56.9

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

8.2

56.4

L04AA01

ATC

[U] ciclosporin

8.2

56.4

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

13.0

56.3

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.2

56.1

573

2893

R81

ICPC

Pneumonia

3.6

56.0

192

555

E66.00

ICD-10 Finland

Metabolic syndrome

3.2

55.9

238

788

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

8.3

55.6

N02BE01

ATC

paracetamol; systemic, rectal

2.1

55.6

3268

28281

A04AA01

ATC

ondansetron; systemic, rectal

2.7

55.1

315

1227

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

9.4

54.6

N19

ICD-10 Finland

Unspecified kidney failure

3.5

54.3

193

571

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.6

54.3

340

1385

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.6

54.3

346

1422

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

13.2

53.7

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

53.7

679

3707

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

11.4

53.6

XF600

NOMESCO Finland

Bloodpressure measurement

2.8

52.8

291

1111

I50

ICD-10 Finland

Heart failure

3.7

52.6

171

477

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.8

52.5

285

1080

E66.8

ICD-10 Finland

Other obesity

3.4

52.3

193

585

B03XA01

ATC

erythropoietin; parenteral

8.4

52.3

E0000UV, ,

ATC

1.7

52.3

1476

10298

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

5.7

52.1

176

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.9

52.1

253

903

WX725

NOMESCO Finland

Noninvasive ventilation

3.0

52.0

243

849

SPAT1229

SPAT

Assessment of need for aid

2.5

51.9

338

1403

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

8.8

51.8

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

7.3

51.7

106

WX722

NOMESCO Finland

PEEP

3.1

51.4

228

773

WW300

NOMESCO Finland

Transfer of autologic stem cells

20.7

51.4

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.0

51.4

112

230

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.0

51.4

148

379

Z51.5

ICD-10 Finland

Palliative care

2.5

51.1

347

1468

K78

ICPC

Atrial fibrillation/flutter

2.4

50.5

390

1750

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.7

50.4

279

1068

NGQ20

NOMESCO Finland

Amputation of lower leg

13.6

50.2

L04AX04

ATC

lenalidomide; oral

10.3

50.2

L03.9

ICD-10 Finland

Cellulitis, unspecified

5.1

50.1

106

212

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.3

49.9

200

638

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

11.7

49.9

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

11.7

49.9

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.8

49.8

272

1033

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.5

49.4

174

512

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

4.9

49.4

111

234

A06AD11

ATC

lactulose; oral

2.0

49.1

627

3426

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

4.5

48.9

120

272

Z49.2

ICD-10 Finland

Other dialysis

9.6

48.6

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

13.3

48.5

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

13.8

48.5

R18

ICD-10 Finland

Ascites

4.8

48.4

109

230

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

5.4

48.4

185

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

48.2

982

6224

M00.2

ICD-10 Finland

Other streptococcal arthritis and polyarthritis

89.6

47.9

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

5.8

47.7

152

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.8

47.6

146

391

A08

ICPC

Swelling

3.0

47.2

222

778

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.6

47.1

161

464

B01AF02

ATC

apixaban; oral

2.0

46.7

556

2959

K92.1

ICD-10 Finland

Melaena

2.7

46.5

265

1029

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

11.9

45.4

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

4.8

45.3

103

219

R53

ICD-10 Finland

Malaise and fatigue

1.8

45.1

851

5259

H02AB04

ATC

methylprednisolone; systemic

2.0

45.1

534

2834

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

6.0

45.1

136

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.7

45.0

248

946

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.8

45.0

231

849

A10AE05

ATC

insulin detemir; parenteral

2.8

45.0

241

906

TFP20

NOMESCO Finland

Cardiodefibrillation

2.4

44.9

347

1554

B05DA

ATC

Isotonic solutions

9.3

44.8

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

7.1

44.5

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.8

44.5

226

826

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

5.5

44.4

159

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

44.3

2466

20119

WX402

NOMESCO Finland

General anaesthesia

1.8

44.1

744

4441

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

11.3

44.0

C08CA01

ATC

amlodipine; oral

1.6

43.9

1484

10715

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

4.7

43.7

103

226

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

43.5

1160

7881

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

3.3

43.1

166

517

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.0

43.1

123

313

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

8.4

42.4

321

Kela drug reimbursment

Paricalcitol and cinacalcet

11.1

42.4

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

10.3

42.2

T90

ICPC

Diabetes non-insulin dependent

1.7

42.2

926

5961

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.2

42.0

173

561

B05DB

ATC

Hypertonic solutions

9.9

41.9

H02AB07

ATC

prednisone; oral

2.0

41.8

506

2702

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

6.5

41.7

106

Z72.2

ICD-10 Finland

Drug use

13.6

41.7

J01CE02

ATC

phenoxymethylpenicillin; oral

1.6

41.5

2325

18845

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

41.4

613

3505

E66.01

ICD-10 Finland

Obesity due to excess calories

2.5

41.3

282

1194

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

77.7

40.9

L17

ICPC

Foot/toe symptom/complaint

1.7

40.8

1022

6809

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

40.7

1534

11313

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

7.2

40.7

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

5.1

40.5

169

RD210, ,

NOMESCO Finland

4.8

40.4

196

E87.5

ICD-10 Finland

Hyperkalaemia

4.4

40.3

102

237

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.2

40.2

387

1896

A41.4

ICD-10 Finland

Sepsis due to anaerobes

401.7

40.2

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

4.9

40.0

186

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

13.2

40.0

R03BB04

ATC

tiotropium bromide; inhalant

2.1

39.8

436

2243

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.5

39.8

255

1047

H02AB09

ATC

hydrocortisone; systemic

4.1

39.7

111

278

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

2.5

39.7

261

1085

03800

ICD-8 Finland

Septicaemia, Streptococcal

+∞

39.6

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

39.6

532

2942

UJF32

NOMESCO Finland

Coloscopy

1.7

39.6

967

6393

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.4

39.5

299

1325

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.3

39.5

308

1383

R02

ICPC

Shortness of breath/dyspnoea

2.0

39.3

495

2678

3AC01, ,

NOMESCO Finland

6.6

39.1

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

39.0

659

3920

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

39.0

662

3944

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.9

39.0

118

313

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

5.5

38.9

138

R60.9

ICD-10 Finland

Oedema, unspecified

2.7

38.9

221

856

D70.89

ICD-10 Finland

Neutropenic splenomegaly

6.4

38.8

101

G00.1

ICD-10 Finland

Pneumococcal meningitis

138.1

38.8

0380A

ICD-9 Finland

Septicaemia, Streptococcal septicaemia[SEPTICHAEMIA STREPTOCOCCUC BETAHAEMOLYTICUS]

+∞

38.6

K07

ICPC

Swollen ankles/oedema

2.8

38.6

204

761

ZXA00

NOMESCO Finland

Right side

1.7

38.6

984

6572

A10BA02

ATC

metformin; oral

1.6

38.3

1090

7482

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

38.3

536

3002

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.5

38.3

248

1024

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

7.1

38.1

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.2

38.0

329

1543

R11

ICD-10 Finland

Nausea and vomiting

2.3

38.0

320

1484

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.7

38.0

219

854

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.0

37.9

171

585

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.8

37.6

201

754

A04AA02

ATC

granisetron; systemic, transdermal

2.6

37.6

226

900

J01DA01

ATC

[U] cefalexin

1.6

37.3

2123

17071

R4120

NOMESCO Finland

Occupational therapy

2.4

36.9

262

1128

J15.4

ICD-10 Finland

Pneumonia due to other streptococci

191.9

36.8

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.3

36.7

140

433

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

4.0

36.7

106

272

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.0

36.5

168

581

WX212

NOMESCO Finland

Femoral plexus blockade

3.7

36.4

116

319

TQW80

NOMESCO Finland

Local dermatologic skincare

3.5

36.3

126

367

205

Kela drug reimbursment

Chronic hypertension

1.6

36.2

1089

7558

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

36.2

1363

9978

SPAT1151

SPAT

Treatment of major wounds

5.6

35.9

123

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

3.1

35.7

154

513

L03AA13

ATC

pegfilgrastim; parenteral

3.2

35.7

148

482

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

35.6

131

396

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.8

35.6

189

706

I48.1

ICD-10 Finland

Persistent atrial fibrillation

2.7

35.6

193

729

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.6

35.4

118

335

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.6

35.2

119

341

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

3.3

35.1

132

405

B01AB04

ATC

dalteparin; parenteral

2.6

34.8

211

843

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.1

34.7

378

1938

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

4.0

34.7

252

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

6.5

34.5

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.6

34.5

200

782

H3603, E103,

ICD-10 Finland

7.7

34.4

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

34.4

1083

7584

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

2.7

34.4

195

754

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

7.5

34.4

Z3229

NOMESCO Finland

Other healthcare associate professional

2.1

34.2

337

1663

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

6.3

34.2

ZXA05

NOMESCO Finland

Left side

1.6

34.1

893

5976

A10AB04

ATC

insulin lispro; parenteral

3.4

34.0

127

388

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

9.8

33.9

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

4.0

33.8

252

WX704

NOMESCO Finland

Intubation

2.2

33.7

305

1456

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

5.3

33.6

131

L04AX01

ATC

azathioprine; systemic

3.0

33.3

152

523

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.4

33.2

247

1086

RS220, ,

NOMESCO Finland

5.3

32.9

126

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

6.1

32.8

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

32.7

2248

18578

N05CF01

ATC

zopiclone; oral

1.6

32.7

1144

8192

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

4.8

32.5

154

A10AD05

ATC

insulin aspart; parenteral

3.9

32.4

251

AB2

AVR bio, stent

6.5

32.4

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

7.5

32.2

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.4

32.2

118

356

NFQ20

NOMESCO Finland

Amputation of femur

7.0

32.2

329

Kela drug reimbursment

Lenalidomide

9.2

32.1

R4190

NOMESCO Finland

Nutritional therapy

2.9

32.1

152

534

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

3.4

32.1

117

352

J96.0

ICD-10 Finland

Acute respiratory failure

4.8

32.0

152

I50.1

ICD-10 Finland

Left ventricular failure

2.4

31.9

229

991

Z94.4

ICD-10 Finland

Liver transplant status

12.5

31.5

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

9.6

31.5

WZC30

NOMESCO Finland

Teaching

1.8

31.3

557

3348

0350X

ICD-9 Finland

Erysipelas[ERYSIPELAS ALIA DEFINITA SEU NUD]

+∞

31.3

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.9

31.1

417

2294

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

3.2

31.1

127

410

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.6

31.0

178

692

K77

ICPC

Heart failure

3.5

30.9

108

316

RJ411, ,

NOMESCO Finland

8.4

30.9

X57

ICD-10 Finland

Unspecified privation

3.6

30.8

102

288

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.4

30.7

113

342

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.5

30.7

195

797

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

111.0

30.7

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

30.7

779

5154

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.7

30.6

271

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.4

30.5

209

885

GBB00

NOMESCO Finland

Tracheostomy

5.0

30.5

135

SPAT1301

SPAT

No procedures

1.5

30.5

1116

8048

T89

ICPC

Diabetes insulin dependent

2.8

30.4

156

573

WX320

NOMESCO Finland

Spinalanesthesy

1.6

30.3

861

5853

A10BH01

ATC

sitagliptin; oral

2.0

30.3

369

1966

G00.9

ICD-10 Finland

Bacterial meningitis, unspecified

38.4

30.2

ZX112

NOMESCO Finland

Subcutaneous

3.7

30.1

269

A05AA02

ATC

ursodeoxycholic acid; oral

4.6

30.1

160

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.5

30.1

106

312

K70.4

ICD-10 Finland

Alcoholic hepatic failure

10.1

30.0

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

9.3

30.0

SPAT1211

SPAT

Application of soft bandage

2.0

30.0

332

1709

M13.9

ICD-10 Finland

Arthritis, unspecified

2.2

29.9

256

1193

ZXA10

NOMESCO Finland

Bilateral

1.7

29.9

674

4322

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

3.2

29.9

123

399

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

29.8

947

6608

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

29.8

1373

10388

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.9

29.7

134

P19

ICPC

Drug abuse

7.6

29.7

A04

ICPC

Weakness/tiredness general

1.8

29.7

521

3117

S91.3

ICD-10 Finland

Open wound of other parts of foot

3.4

29.6

108

325

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

9.1

29.5

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

30.3

29.4

A12BA01

ATC

potassium chloride; oral

2.5

29.4

193

801

B34.9

ICD-10 Finland

Viral infection, unspecified

3.3

29.3

112

347

C09AA02

ATC

enalapril; systemic

1.6

29.2

751

4977

F10.20

ICD-10 Finland

Alcohol dependence currently independent

4.0

29.2

211

A10BB12

ATC

glimepiride; oral

2.1

29.1

292

1449

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.7

29.1

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

29.0

925

6455

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.3

28.9

108

330

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.2

28.8

262

1251

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.9

28.8

137

483

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

33.9

28.7

NF1AA

NOMESCO Finland

Hip X-ray examination

2.0

28.7

330

1722

C07AB02

ATC

metoprolol; systemic

1.6

28.6

781

5249

C02AC05

ATC

moxonidine; oral

2.5

28.5

190

794

XX3DW

NOMESCO Finland

Time consuming IT work

1.9

28.4

394

2191

A10BH05

ATC

linagliptin; oral

2.3

28.3

214

946

K08.3

ICD-10 Finland

Retained dental root

2.1

28.3

289

1443

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.7

28.2

157

601

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.8

28.2

142

516

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

6.0

28.1

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

10.4

28.0

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

3.4

28.0

102

307

JN6AD

NOMESCO Finland

CT of torso and neck

4.3

27.9

170

R33

ICD-10 Finland

Retention of urine

2.0

27.8

333

1762

H3601, E113,

ICD-10 Finland

4.1

27.8

192

A10AB01

ATC

insulin (human); parenteral

2.9

27.6

128

445

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.4

27.6

187

788

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.5

27.6

176

721

TGC00

NOMESCO Finland

Bronchial lavation

3.3

27.6

106

330

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

11.2

27.6

S29

ICPC

Skin symptom/complaint other

1.6

27.5

661

4301

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

27.2

1443

11173

ED1AA

NOMESCO Finland

Mandibular X-ray examination

6.7

27.2

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

7.7

27.2

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.4

27.2

293

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

5.3

27.2

106

L70

ICPC

Infection of musculoskeletal system

8.8

27.2

K65.0

ICD-10 Finland

Acute peritonitis

4.7

27.1

133

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

6.2

27.1

ZXD35

NOMESCO Finland

Usual procedure

2.9

26.9

132

473

A10BJ06

ATC

semaglutide; parenteral

2.5

26.9

169

687

PE1AT

NOMESCO Finland

Femoral artery PTA

4.7

26.8

134

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.3

26.8

199

874

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.8

26.7

140

520

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

4.9

26.7

119

WVA20

NOMESCO Finland

Medicine administration

3.2

26.6

105

332

H3603, E113,

ICD-10 Finland

5.6

26.6

WVA20, ,

SPAT

3.2

26.5

107

343

TK820

NOMESCO Finland

Peritoneal dialysis

10.1

26.5

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

4.4

26.4

156

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

4.2

26.4

173

S91.1

ICD-10 Finland

Open wound of toe(s) without damage to nail

4.4

26.4

152

XCK10

NOMESCO Finland

Photography of fundus of eye

1.9

26.4

361

1996

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.8

26.3

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.6

26.3

150

582

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.3

26.2

206

926

E000001, ,

ATC

1.6

26.2

645

4217

H3600, E113,

ICD-10 Finland

4.4

26.2

153

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.7

26.2

141

531

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.6

26.2

151

589

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

5.1

26.1

110

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

26.1

259

1280

P01AB01

ATC

metronidazole; oral, rectal

1.5

26.0

1213

9139

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.4

25.9

190

829

G06.1

ICD-10 Finland

Intraspinal abscess and granuloma

94.1

25.7

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

4.2

25.7

164

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.8

25.5

392

2247

R31

ICD-10 Finland

Unspecified haematuria

1.8

25.5

414

2413

K83

ICPC

Heart valve disease NOS

4.5

25.4

140

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.1

25.4

268

1354

L84

ICD-10 Finland

Corns and callosities

2.7

25.4

139

528

D07AC01

ATC

betamethasone; topical

1.5

25.4

1191

8974

M79.6

ICD-10 Finland

Pain in limb

1.5

25.4

1322

10166

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

25.3

660

4375

U14

ICPC

Kidney symptom/complaint

3.7

25.2

215

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.9

25.2

197

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.4

25.2

173

733

0380X

ICD-9 Finland

Septicaemia, Streptococcal septicaemia[SEPTICHAEMIA STREPTOCOCCUS ALIA]

+∞

25.0

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.8

25.0

118

XF404

NOMESCO Finland

Ambulatory ECG

1.9

25.0

338

1862

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

24.9

437

2606

HA1AA

NOMESCO Finland

X-ray mammography

2.2

24.9

211

979

R03AC02

ATC

salbutamol; inhalant

1.4

24.8

1772

14427

A29

ICPC

General symptom/complaint other

1.8

24.8

445

2672

I34.1

ICD-10 Finland

Mitral (valve) prolapse

2.8

24.7

122

439

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.4

24.7

168

709

K70

ICPC

Infection of circulatory system

251.8

24.7

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

24.7

296

1566

UKC02

NOMESCO Finland

Cystoscopy

1.6

24.6

640

4235

D09AB01

ATC

zinc bandage without supplements; topical

3.6

24.6

233

C09AA05

ATC

ramipril; oral

1.5

24.5

950

6877

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

24.5

262

1331

AN1

Coronary angiography

1.7

24.4

456

2769

160

Kela drug reimbursment

exenatide

3.7

24.4

211

C03AA03

ATC

hydrochlorothiazide; oral

1.9

24.4

345

1928

M05BX04

ATC

denosumab; parenteral

2.2

24.3

207

962

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.2

24.3

314

P15

ICPC

Chronic alcohol abuse

3.0

24.3

109

372

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.3

24.3

294

A10BJ02

ATC

liraglutide; parenteral

3.1

24.3

100

325

I44.2

ICD-10 Finland

Atrioventricular block, complete

2.7

24.2

134

512

J96.1

ICD-10 Finland

Chronic respiratory failure

3.1

24.1

100

326

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

2.3

24.1

183

811

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

8.4

24.0

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

8.4

24.0

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.2

24.0

151

A40

ICD-10 Finland

Streptococcal sepsis

+∞

24.0

SPAT1216

SPAT

Assessment of functional ability

1.6

23.8

563

3639

SPAT1260

SPAT

Consultation of another employee

1.6

23.7

596

3908

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

23.7

333

1855

A07AA02

ATC

nystatin; oral

2.2

23.7

210

992

M72.6

ICD-10 Finland

Necrotizing fasciitis

41.7

23.6

JN4CD

NOMESCO Finland

Very extensive body CT

2.6

23.6

144

578

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.2

23.5

149

NF3AA

NOMESCO Finland

Femur X-ray examination

3.2

23.5

285

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.2

23.4

198

918

E86

ICD-10 Finland

Volume depletion

3.0

23.3

102

343

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.3

23.3

176

778

QDB10, ,

SPAT

3.7

23.3

199

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.8

23.3

115

414

ZY010

NOMESCO Finland

Hospital outpatient

2.4

23.3

162

691

R04.0

ICD-10 Finland

Epistaxis

1.9

23.2

296

1599

E66.9

ICD-10 Finland

Obesity, unspecified

2.9

23.1

111

394

QCA10

NOMESCO Finland

Incision of skin of upper limb

9.1

23.0

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

22.9

286

1532

N08.0*A40.9

ICD-10 Finland

Glomerular disease in streptococcal septicemia

+∞

22.9

3025

Kela drug reimbursment

Calcium carbonate

6.9

22.9

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.9

22.9

296

1605

R4180

NOMESCO Finland

Podiatric therapy

4.6

22.9

119

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.4

22.6

237

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.6

22.5

133

525

H36.01

ICD-10 Finland

Diabetic maculopathy

4.1

22.5

154

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

22.5

1124

8529

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.9

22.4

107

378

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.7

22.4

119

445

Z71.8

ICD-10 Finland

Other specified counselling

1.5

22.4

953

7009

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

3.7

22.3

196

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

8.3

22.3

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

22.2

632

4263

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

22.2

376

2216

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

22.2

404

2431

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

6.5

22.2

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

4.7

22.2

110

D07AA02

ATC

hydrocortisone; topical

1.7

22.2

448

2776

M10.3

ICD-10 Finland

Gout due to impairment of renal function

7.9

22.1

SPAT1172

SPAT

Guidance concerning hydration

3.1

22.1

301

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

5.7

22.1

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.9

22.1

104

365

EBA10

NOMESCO Finland

Operative extraction of tooth

1.8

22.1

379

2244

ZXE90

NOMESCO Finland

More than 22 hours

5.5

21.9

J94.8

ICD-10 Finland

Other specified pleural conditions

3.5

21.9

222

A41.2

ICD-10 Finland

Sepsis due to unspecified staphylococcus

+∞

21.9

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

8.1

21.8

N02BF02

ATC

pregabalin; oral

2.2

21.7

190

893

NH1AD

NOMESCO Finland

Ankle and foot CT

3.2

21.7

268

I33.9

ICD-10 Finland

Acute endocarditis, unspecified

18.5

21.7

D65

ICD-10 Finland

Disseminated intravascular coagulation [defibrination syndrome]

115.7

21.6

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.3

21.6

254

R5110, ,

SPAT

2.0

21.4

231

1176

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.6

21.3

125

492

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

4.4

21.3

122

A02BC01

ATC

omeprazole; systemic

1.5

21.3

917

6752

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

21.3

931

6876

M86.6

ICD-10 Finland

Other chronic osteomyelitis

23.2

21.2

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

21.2

850

6168

RJ420, ,

NOMESCO Finland

7.6

21.2

L01AA01

ATC

cyclophosphamide; systemic

7.3

21.2

212

Kela drug reimbursment

Gout

3.0

21.2

314

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.0

21.1

309

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.1

21.1

213

1058

N05AH04

ATC

quetiapine; oral

1.6

21.1

529

3460

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

8.5

21.0

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

4.7

21.0

103

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

3.6

21.0

190

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

20.9

546

3607

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

5.0

20.9

J05AB11

ATC

valaciclovir; oral

1.7

20.9

442

2770

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.1

20.8

141

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

20.8

1224

9540

QXB10

NOMESCO Finland

Exchange of dressing for large skin wound, unspecified location

19.5

20.8

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.9

20.7

264

1424

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

5.7

20.7

L03.3

ICD-10 Finland

Cellulitis of trunk

5.7

20.7

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

8.7

20.6

A49.1

ICD-10 Finland

Streptococcal and enterococcal infection, unspecified site

211.1

20.6

WX203

NOMESCO Finland

Infraclavicular plexus blockade

3.1

20.4

289

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.4

20.3

136

570

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.0

20.2

306

S11

ICPC

Skin infection post-traumatic

3.9

20.2

153

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

20.2

292

1641

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.8

20.2

167

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

8.4

20.1

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.7

20.1

172

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

4.5

20.1

111

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.3

20.1

240

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

4.6

20.1

103

S20

ICPC

Corn/callosity

3.0

20.0

292

GD1LA

NOMESCO Finland

3.4

20.0

206

3A064, ,

NOMESCO Finland

7.6

19.9

J80

ICD-10 Finland

Adult respiratory distress syndrome

7.3

19.9

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

19.9

328

1917

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

20.9

19.9

N30.0

ICD-10 Finland

Acute cystitis

1.6

19.8

467

3007

S17

ICPC

Abrasion/scratch/blister

2.8

19.7

360

K75.0

ICD-10 Finland

Abscess of liver

15.4

19.7

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

3.5

19.6

189

ZX120, ,

SPAT

4.8

19.6

KBV00

NOMESCO Finland

Insertion of stent into ureter

5.9

19.6

K28

ICPC

Limited function/disability (K)

2.9

19.6

328

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.6

19.6

117

465

J01CR50

ATC

combinations of penicillins; systemic

105.6

19.6

N03AX12

ATC

[U] gabapentin; oral

1.6

19.5

511

3373

RS221, ,

NOMESCO Finland

3.8

19.5

157

R06AE07

ATC

cetirizine; oral

1.4

19.5

1299

10315

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.1

19.5

270

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

7.4

19.5

K83.0

ICD-10 Finland

Cholangitis

3.6

19.4

176

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

19.4

260

1426

U04

ICPC

Incontinence urine

2.1

19.4

195

968

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.6

19.3

548

3686

S19

ICPC

Skin injury other

2.3

19.3

149

666

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.0

19.2

199

998

A49

ICD-10 Finland

Bacterial infection of unspecified site

31.4

19.2

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.5

19.2

124

512

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

19.1

394

2449

RJ410, ,

NOMESCO Finland

7.9

19.1

NH3CG

NOMESCO Finland

Extensive MRI of foot

6.7

19.1

HAC20

NOMESCO Finland

Total mastectomy

2.6

19.1

114

453

N06AX11

ATC

mirtazapine; oral

1.4

19.0

1048

8048

L14

ICPC

Leg/thigh symptom/complaint

1.9

19.0

265

1472

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

4.8

18.9

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.1

18.9

178

862

ZXD40

NOMESCO Finland

Procedure on patient requiring isolation

15.9

18.8

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

3.9

18.7

139

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

6.6

18.7

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

18.7

390

2432

M10.0

ICD-10 Finland

Idiopathic gout

2.4

18.7

130

555

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

4.6

18.7

J02AC01

ATC

fluconazole; systemic

1.4

18.5

1023

7853

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

4.3

18.5

110

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

3.6

18.4

173

B01AC04

ATC

clopidogrel; oral

1.5

18.4

637

4474

J46

ICD-10 Finland

Status asthmaticus

2.7

18.4

357

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

18.3

1166

9169

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.5

18.2

179

5CM18, ,

NOMESCO Finland

6.9

18.2

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

7.1

18.2

QD6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in foot

21.8

18.2

K02.1

ICD-10 Finland

Caries of dentine

1.4

18.1

1834

15512

N05BA04

ATC

oxazepam; oral

1.5

18.1

800

5894

GD1UN

NOMESCO Finland

Lung circulation SPECT

5.7

18.0

E000006, ,

ATC

2.0

18.0

214

1127

D64.8

ICD-10 Finland

Other specified anaemias

3.1

18.0

251

N05CD07

ATC

temazepam; oral

1.6

18.0

412

2631

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

4.8

18.0

L03AA14

ATC

lipegfilgrastim; parenteral

3.6

17.9

162

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.2

17.9

231

SPAT1234

SPAT

Support of social functional capacity

2.0

17.8

186

936

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

5.0

17.8

H3601, E103,

ICD-10 Finland

5.3

17.8

SPAT1227

SPAT

Substance abuse rehabilitation

6.0

17.8

M86.1

ICD-10 Finland

Other acute osteomyelitis

18.1

17.8

G47.3

ICD-10 Finland

Sleep apnoea

1.5

17.7

713

5155

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.6

17.7

168

M46.2

ICD-10 Finland

Osteomyelitis of vertebra

66.9

17.7

S06

ICPC

Rash localized

2.0

17.7

188

952

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.9

17.6

238

1308

D07BC01

ATC

betamethasone and antiseptics; topical

1.7

17.6

385

2429

K72.9

ICD-10 Finland

Hepatic failure, unspecified

6.3

17.5

E000003, ,

ATC

2.2

17.5

141

641

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

17.5

1344

10872

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.4

17.5

120

509

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.6

17.5

160

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.4

17.5

189

N07BB01

ATC

disulfiram; oral

2.3

17.5

136

610

K86.3

ICD-10 Finland

Pseudocyst of pancreas

6.6

17.5

AP2

Catheterization of the right side of the heart

6.8

17.4

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

6.8

17.4

PD4BD

NOMESCO Finland

Extensive CT of lower extremity arteries

7.1

17.4

M10

ICD-10 Finland

Gout

2.1

17.4

165

802

E87.6

ICD-10 Finland

Hypokalaemia

2.4

17.4

119

505

C08CA13

ATC

lercanidipine; oral

1.6

17.4

490

3288

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.7

17.3

147

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.7

17.3

147

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

4.5

17.3

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.1

17.2

170

839

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.5

17.1

111

459

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

4.3

17.1

104

W19

ICD-10 Finland

Unspecified fall

1.7

17.1

330

2015

C01DA14

ATC

isosorbide mononitrate; oral

1.5

17.1

624

4424

L30.3

ICD-10 Finland

Infective dermatitis

2.4

17.0

118

503

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

16.0

17.0

SPAT1167

SPAT

Insertion of urinary catheter

2.3

17.0

123

535

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

7.5

17.0

S01

ICPC

Pain/tenderness of skin

2.2

17.0

148

696

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.0

16.9

190

982

D07AB08

ATC

desonide; topical

1.7

16.9

336

2068

PD5AD

NOMESCO Finland

CT of aorta

2.7

16.9

327

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

19.3

16.8

JJC00

NOMESCO Finland

Allogenic transplantation of liver

19.3

16.8

E87.2

ICD-10 Finland

Acidosis

6.1

16.8

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

16.8

429

2810

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.1

16.7

162

793

P16

ICPC

Acute alcohol abuse

3.4

16.7

175

PB1AC

NOMESCO Finland

Angiography of upper extremity with X-ray

35.2

16.7

K70.1

ICD-10 Finland

Alcoholic hepatitis

6.5

16.6

RJ414, ,

NOMESCO Finland

15.1

16.6

C01BD01

ATC

amiodarone; systemic

2.4

16.6

114

484

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

12.7

16.6

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

3.9

16.6

124

TQW40

NOMESCO Finland

Remowal of suture of skin

1.9

16.6

231

1282

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

4.6

16.6

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

2.3

16.5

125

554

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

7.0

16.5

EBA00

NOMESCO Finland

Extraction of tooth

1.4

16.5

1136

9014

A10AA02, ,

ATC

2.4

16.5

115

492

NH2AA

NOMESCO Finland

Heel X-ray examination

5.6

16.5

115

Kela drug reimbursment

Breast cancer

1.9

16.5

209

1126

R41.0

ICD-10 Finland

Disorientation, unspecified

2.4

16.5

118

511

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

16.5

623

4446

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

3.9

16.4

125

RS230, ,

NOMESCO Finland

5.8

16.2

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.7

16.1

282

1675

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

2.3

16.1

116

503

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.8

16.1

238

1345

A04AD12

ATC

aprepitant; systemic

3.3

16.1

179

E66.0

ICD-10 Finland

Obesity due to excess calories

4.5

16.1

RJ421, ,

NOMESCO Finland

7.1

16.1

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

16.0

246

1407

XG466

NOMESCO Finland

Sleep oxymetry

2.4

16.0

108

455

R03BA05

ATC

fluticasone; inhalant

1.5

16.0

546

3813

WX890

NOMESCO Finland

Intesive care monitoring

4.3

16.0

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

15.9

194

1031

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

15.9

896

6873

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.1

15.9

149

721

A10AA01, ,

ATC

2.8

15.9

298

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

6.4

15.8

QDE35

NOMESCO Finland

Repair of skin defect in lower limb after surgery or injury

6.4

15.8

C07AG02

ATC

carvedilol; oral

1.9

15.8

214

1178

D01AC02

ATC

miconazole; topical

1.8

15.8

260

1519

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

2.0

15.8

179

929

I81

ICD-10 Finland

Portal vein thrombosis

6.6

15.7

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

33.5

15.7

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.3

15.7

172

NGC00

NOMESCO Finland

Exchange of a loose part of prosthesis in knee joint

5.5

15.7

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.3

15.7

177

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.3

15.7

182

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

15.7

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

7.2

15.7

K99

ICPC

Cardiovascular disease other

2.4

15.7

108

460

J96.9

ICD-10 Finland

Respiratory failure, unspecified

4.8

15.6

PWE00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system

6.0

15.6

AC4

MVP

6.0

15.6

120

Kela drug reimbursment

Hypogammaglobulinaemia

26.4

15.6

N05BA01

ATC

diazepam; systemic, rectal

1.6

15.5

405

2665

K84

ICPC

Heart disease other

2.3

15.5

113

493

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

15.5

579

4117

S01.0

ICD-10 Finland

Open wound of scalp

1.7

15.5

275

1641

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

2.0

15.5

170

872

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.3

15.4

179

J01CF02

ATC

cloxacillin; systemic

2.8

15.4

280

F05.9

ICD-10 Finland

Delirium, unspecified

2.7

15.4

314

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

4.6

15.4

H26.3

ICD-10 Finland

Drug-induced cataract

5.7

15.4

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

3.9

15.4

113

JAH00

NOMESCO Finland

Laparotomy

2.5

15.3

409

NGS10

NOMESCO Finland

Incision and debridement of infection of knee joint

12.4

15.3

TPH04, ,

SPAT

5.2

15.3

N03AG01

ATC

valproic acid; systemic, rectal

2.0

15.2

175

912

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.7

15.2

299

Y88.1

ICD-10 Finland

Sequelae of misadventures to patients during surgical and medical procedures

3.4

15.2

156

PD4AD

NOMESCO Finland

CT of lower extremity arteries

4.9

15.2

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.5

15.2

387

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

4.8

15.2

F10.24

ICD-10 Finland

Alcohol depence active use

3.3

15.2

166

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

4.1

15.1

101

-50

ICPC

Medication/prescr/renewal

2.1

15.1

143

695

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

3.1

15.1

197

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

14.0

15.0

6BA02, ,

NOMESCO Finland

14.0

15.0

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

3.5

15.0

143

B82

ICPC

Anaemia other/unspecified

2.4

15.0

100

420

RS222, ,

NOMESCO Finland

3.7

15.0

129

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.9

14.9

177

932

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

4.5

14.9

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

2.7

14.9

302

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.6

14.9

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

5.8

14.9

SPAT1104

SPAT

Monitoring of emergency patient

1.8

14.9

223

1266

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

2.2

14.8

121

554

WX610

NOMESCO Finland

Patient controlled analgesia

5.2

14.8

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.3

14.8

108

472

A49.0

ICD-10 Finland

Staphylococcal infection, unspecified site

56.9

14.8

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

16.5

14.7

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

16.5

14.7

GAC97

NOMESCO Finland

Other endoscopic operation on pleura

11.3

14.7

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

4.4

14.7

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

4.4

14.7

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.8

14.7

276

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

4.7

14.7

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

3.0

14.7

216

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.9

14.7

243

Z43.5

ICD-10 Finland

Attention to cystostomy

5.3

14.6

S21

ICPC

Skin texture symptom/complaint

1.5

14.6

456

3121

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

5.7

14.6

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

5.7

14.6

N08.0*A41.9

ICD-10 Finland

Glomerular disease in unspecified septicemia

+∞

14.6

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.1

14.6

201

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

14.6

330

2099

B04

ICPC

Blood symptom/complaint

5.1

14.6

WX720

NOMESCO Finland

Own respiration

2.0

14.6

161

828

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

14.2

14.5

A06AH03

ATC

naloxegol; oral

3.3

14.5

166

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.3

14.5

112

502

NF1AT

NOMESCO Finland

Puncture of hip joint with ultrasound guidance

5.4

14.5

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

6.6

14.5

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

6.6

14.5

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.5

14.4

366

N05BA06

ATC

lorazepam; systemic, sublingual

2.0

14.4

165

859

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

15.4

14.4

PD5BD

NOMESCO Finland

Extensive CT of aorta

2.6

14.4

308

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.8

14.3

110

X58

ICD-10 Finland

Exposure to other specified factors

1.5

14.3

417

2814

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

14.3

264

1593

TPX15

NOMESCO Finland

Removal of vascular injection port

11.4

14.3

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

11.4

14.3

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.7

14.2

298

C08CA02

ATC

felodipine; oral

1.6

14.2

338

2175

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

4.7

14.2

J01DA06

ATC

[U] cefuroxime

1.5

14.2

410

2759

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

22.3

14.2

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

22.3

14.2

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

13.4

14.2

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.3

14.2

105

462

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.2

14.2

123

578

H04AA01

ATC

glucagon; nasal, parenteral

2.8

14.1

248

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

3.5

14.1

139

SPAT1088

SPAT

Blood transfusion

5.1

14.1

A01

ICPC

Pain general/multiple sites

1.7

14.1

271

1653

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.1

14.0

195

R10.0

ICD-10 Finland

Acute abdomen

2.3

14.0

102

445

G72.8

ICD-10 Finland

Other specified myopathies

3.1

14.0

190

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

4.1

13.9

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

30.1

13.9

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

30.1

13.9

SPAT1265

SPAT

Breathalyser

4.2

13.9

WW409

NOMESCO Finland

Other aferesis

17.6

13.8

U70

ICPC

Pyelonephritis/pyelitis

3.4

13.8

146

PJ1AN

NOMESCO Finland

Lymphsystem isotope imaging

53.5

13.8

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

4.4

13.8

H62.0*A46

ICD-10 Finland

Otitis externa in erysipelas

11.4

13.8

WX199

NOMESCO Finland

Other local analgesia

2.2

13.8

120

565

XQ902

NOMESCO Finland

Other photography

4.7

13.8

R03DA04

ATC

theophylline; systemic, rectal

1.9

13.7

182

995

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

13.7

184

1011

KA3EB

NOMESCO Finland

Antegrade pyelography

5.7

13.7

K29

ICPC

Cardiovascular sympt/complt other

2.0

13.6

154

798

B29

ICPC

Lymph/immune mech sympt/complt other

6.5

13.6

S70

ICPC

Herpes zoster

2.4

13.6

407

UJK02

NOMESCO Finland

ERCP

2.4

13.6

365

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

13.5

322

2072

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

3.0

13.5

194

M86.4

ICD-10 Finland

Chronic osteomyelitis with draining sinus

34.1

13.5

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

16.2

13.4

UJF92

NOMESCO Finland

Capsular endoscopy

2.7

13.3

256

YNB10

NOMESCO Finland

Collection of stem cells for transplant

21.2

13.3

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.5

13.3

338

T82

ICPC

Obesity

2.3

13.3

424

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

5.3

13.2

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.1

13.2

119

568

N05AH03

ATC

olanzapine; systemic

1.9

13.2

170

922

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.1

13.2

171

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

2.6

13.1

281

OAB43, ,

SPAT

0.6

13.1

303

4591

S09

ICPC

Infected finger/toe

2.2

13.1

109

504

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

4.9

13.1

B02.9

ICD-10 Finland

Zoster without complication

1.8

13.1

207

1196

I95.9

ICD-10 Finland

Hypotension, unspecified

2.8

13.0

220

SPAT1304

SPAT

Counselling and guidance related to ageing

1.7

13.0

256

1570

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

13.0

386

2612

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

2.6

13.0

300

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.0

13.0

130

646

N03AE01

ATC

clonazepam; systemic

1.9

12.9

175

964

Z22.3

ICD-10 Finland

Carrier of other specified bacterial diseases

13.0

12.9

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

4.3

12.9

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

19.1

12.9

OAB50, ,

SPAT

1.8

12.9

180

1001

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.4

12.9

374

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

12.9

1218

10051

R52.0

ICD-10 Finland

Acute pain

2.2

12.9

101

456

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

2.4

12.9

362

XPX08

NOMESCO Finland

Intraoperative flow measurement

3.6

12.8

114

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.5

12.8

338

WX870

NOMESCO Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

1014

2883

4.43

307.65

2.7

1.5

—

(3023368) Bacteria identified in Blood by Culture

2564

6798

9.53

307.65

9.3

3.0

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

588

810

8.41

307.65

2.4

1.6

4.25

1.95

ug/l

2.03

536

673

(3020779) Urea [Moles/volume] in Serum or Plasma

954

2417

4.94

307.65

14.2

5.6

12.07

9.52

mmol/l

17.12

916

2277

(3042936) Bacteria identified in Isolate by Culture

1313

3487

5.23

307.65

3.3

1.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1160

3532

4.29

307.65

12.3

4.6

1.10

1.04

mmol/l

8.60

1091

3245

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1544

4203

5.50

307.65

2.6

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1119

2903

5.05

307.65

2.3

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1130

2894

5.13

307.65

2.3

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

763

1677

5.44

307.65

2.2

1.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1291

4371

3.96

307.65

5.7

2.9

0.80

0.82

mmol/l

7.28

1209

4058

(40760892) CBC W Ordered Manual Differential panel - Blood

2480

13123

3.56

304.26

11.4

5.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1038

3154

4.15

301.85

5.4

3.8

252.98

240.00

u/l

1.74

996

2957

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

284

218

14.00

301.41

8.0

5.6

11.63

11.21

mg/l

0.61

263

199

(3019069) Monocytes/100 leukocytes in Blood

2471

13168

3.51

297.03

11.3

5.5

8.51

8.80

3.95

2380

12219

(3022096) Basophils/100 leukocytes in Blood

2409

12668

3.47

295.38

10.8

5.3

0.58

0.68

16.54

2309

11714

(3006504) Eosinophils/100 leukocytes in Blood

2456

13095

3.48

293.76

10.9

5.2

2.57

2.94

12.02

2365

12131

(3002030) Lymphocytes/100 leukocytes in Blood

2491

13530

3.44

286.09

11.0

5.3

23.05

28.15

74.17

2400

12595

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2612

14702

3.49

280.61

11.4

5.2

12.20

12.23

umol/l

0.04

2527

13890

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1113

3754

3.78

275.98

4.3

2.2

20.14

23.49

11.20

972

3184

(3001604) Monocytes [#/volume] in Blood

2525

14014

3.39

275.76

10.4

5.0

0.64

0.60

e9/l

10.65

2224

11958

(3006315) Basophils [#/volume] in Blood

2527

14047

3.39

274.92

10.5

5.0

0.04

e9/l

1.49

2227

11986

(3012544) pH of Venous blood

911

2692

4.14

272.86

7.1

3.3

7.37

7.40

1.06

(3018010) Neutrophils/100 leukocytes in Blood

2440

13346

3.32

271.54

10.6

5.1

61.48

56.83

52.02

2342

12407

(3019198) Lymphocytes [#/volume] in Blood

2562

14433

3.38

270.94

10.5

5.1

1.77

1.96

e9/l

2.43

2287

12600

(3027945) Reticulocytes/100 erythrocytes in Blood

1032

3345

3.86

270.83

3.7

2.3

1.92

1.67

9.81

932

2916

(3013115) Eosinophils [#/volume] in Blood

2569

14548

3.37

268.18

11.1

5.2

0.19

0.20

e9/l

1.58

2294

12580

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1139

3999

3.64

264.49

4.3

2.2

2.16

2.33

g/l

18.81

1081

3679

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

344

424

8.82

262.69

1.7

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

480

859

6.25

261.13

3.7

2.6

0.29

0.35

u/ml

2.80

293

464

(3021447) Carbon dioxide [Partial pressure] in Venous blood

875

2589

4.09

260.63

7.1

3.2

5.75

5.86

kpa

2.34

841

2523

(3002032) Base excess in Venous blood by calculation

866

2588

4.04

253.85

7.2

3.2

1.53

1.97

mmol/l

2.48

736

2162

(3022948) Iron [Moles/volume] in Serum or Plasma

1177

4365

3.46

248.97

4.3

2.2

10.43

13.57

umol/l

40.78

1110

4043

(3022217) INR in Platelet poor plasma by Coagulation assay

2490

14211

3.18

248.86

29.0

15.0

1.43

1.32

inr

4.97

771

4014

(3013650) Neutrophils [#/volume] in Blood by Automated count

2721

16439

3.31

244.24

16.9

7.2

4.75

4.10

e9/l

24.87

2450

14128

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

400

638

6.89

243.31

2.2

1.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

979

3305

3.64

238.74

10.6

6.5

5.02

5.09

kpa

1.17

920

3148

(3027801) Oxygen [Partial pressure] in Arterial blood

978

3306

3.64

237.94

10.6

6.4

10.85

12.58

kpa

26.09

920

3145

(3024561) Albumin [Mass/volume] in Serum or Plasma

2265

12468

3.02

237.40

9.9

4.2

32.04

35.84

g/l

125.43

2145

11501

(3003396) Base excess in Arterial blood by calculation

969

3287

3.62

234.12

10.6

6.5

1.11

1.00

mmol/l

0.31

775

2597

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

542

1201

5.10

232.42

2.3

1.6

1.66

1.44

g/l

4.71

466

1012

(3005719) IgG [Mass/volume] in Serum or Plasma

678

1819

4.32

228.74

4.1

2.5

11.42

10.58

g/l

2.57

630

1644

(3014111) Lactate [Moles/volume] in Serum or Plasma

787

2394

3.89

222.73

10.1

6.6

1.53

1.34

mmol/l

2.50

759

2336

(3000991) Gas panel - Venous blood

784

2382

3.89

222.23

13.3

7.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

338

504

7.26

218.47

1.9

1.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2315

13273

2.91

218.14

13.8

5.1

1.19

1.21

mmol/l

28.80

2190

11933

(3023520) Reticulocytes [#/volume] in Blood

802

2509

3.78

217.49

3.8

2.3

70.76

66.77

e9/l

1.93

604

1902

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2461

14645

2.93

214.81

15.8

5.6

1.20

1.21

mmol/l

27.49

2141

12389

(3028026) IgM [Mass/volume] in Serum or Plasma

567

1406

4.56

211.07

2.4

1.9

1.35

1.42

g/l

0.16

515

1266

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

328

496

7.14

209.13

1.9

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

596

1551

4.37

208.33

2.2

1.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

567

1422

4.51

207.91

1.6

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

279

353

8.45

207.84

7.1

6.5

778.95

358.29

iu/ml

0.44

(3016502) Oxygen saturation in Arterial blood

868

2996

3.46

201.26

11.1

6.8

94.60

95.77

4.56

838

2883

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

318

493

6.95

197.91

1.5

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

318

493

6.95

197.91

1.5

1.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1532

7376

2.81

196.83

2.9

2.1

3.41

2.90

mg/l

10.78

1332

6209

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1117

4565

3.05

194.22

3.2

1.9

31.03

29.82

5.92

1087

4429

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

530

1351

4.40

189.56

7.7

3.5

23.71

24.14

mmol/l

2.19

512

1328

(3020630) Protein [Mass/volume] in Serum or Plasma

716

2291

3.62

185.62

4.2

2.3

65.69

66.74

g/l

2.26

664

2055

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

752

2493

3.51

184.51

3.0

2.2

0.19

0.21

g/l

16.25

694

2329

(3013826) Glucose [Moles/volume] in Serum or Plasma

2678

17433

2.82

183.24

10.7

4.1

7.20

6.75

mmol/l

17.17

2578

16299

(3024354) Oxygen [Partial pressure] in Venous blood

686

2162

3.65

181.73

5.4

2.9

4.92

4.53

kpa

3.57

656

2106

(3002582) Erythrocytes [#/volume] in Urine

1705

8955

2.64

180.53

4.7

3.0

118.84

84.90

e6/l

0.33

1388

6837

(3023183) Ammonium ion [Moles/volume] in Plasma

300

494

6.51

175.86

4.3

2.8

35.05

35.21

umol/l

0.03

278

442

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1694

8978

2.60

174.55

4.4

2.8

3021.46

1324.15

ng/l

16.80

1517

7679

(3030467) Casts [#/volume] in Urine by Automated count

1580

8139

2.61

172.18

4.6

3.0

0.67

0.40

e6/l

3.09

1280

6145

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

400

877

4.98

172.02

2.8

2.1

568.41

446.70

ug/l

0.46

382

833

(3014576) Chloride [Moles/volume] in Serum or Plasma

921

3593

3.06

171.37

12.0

6.2

103.96

104.63

mmol/l

3.97

921

3593

(46235355) HIV 1 and 2 tests - Meaningful Use set

964

3871

3.00

170.26

2.1

1.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

343

676

5.48

166.54

1.5

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

771

2759

3.25

165.88

12.1

7.1

114.41

123.44

g/l

25.95

751

2679

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

243

342

7.52

164.80

1.6

1.4

—

(3017181) Myelocytes/100 leukocytes in Blood

661

2177

3.47

162.45

4.9

3.8

0.99

0.87

0.67

401

591

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

214

264

8.53

162.32

4.1

3.6

848.63

1035.11

u/ml

0.08

(3026008) Bacteria identified in Urine by Culture

1595

8439

2.53

161.98

4.1

2.9

—

(36304419) Bacteria [Presence] in Urine

1525

7924

2.54

160.68

4.6

2.9

—

(3018095) Leukocytes [#/volume] in Urine

1826

10318

2.48

160.32

5.4

3.4

89.65

100.69

e6/l

0.29

1434

7311

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

578

1772

3.67

158.38

6.9

3.3

1.79

1.65

mmol/l

0.35

443

1268

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

247

371

7.05

157.84

1.9

1.6

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2781

19174

2.68

156.79

6.6

4.1

378.82

1773.91

e6/l

2.01

288

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

218

293

7.83

153.82

1.6

1.3

—

(3009343) pH of Capillary blood

583

1831

3.58

153.78

7.1

3.4

7.41

0.24

102

193

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

587

1861

3.55

152.54

7.1

3.4

5.08

5.15

kpa

1.22

559

1754

(3000850) Epithelial cells [#/volume] in Urine

1274

6216

2.58

151.62

3.9

2.4

7.00

4.54

e6/l

4.80

1196

5528

(3004588) Protein electrophoresis panel - Serum or Plasma

587

1873

3.52

150.95

4.1

2.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

567

1774

3.58

150.25

11.1

7.1

24.52

24.85

mmol/l

1.04

562

1761

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1599

8763

2.42

146.84

5.3

2.9

42.28

34.57

u/l

1.06

1507

8289

(3026782) Osmolality of Urine

1218

5894

2.57

146.65

4.0

2.6

515.76

561.62

mosm/kgh2o

11.35

1098

5001

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

198

254

8.17

145.27

1.7

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1597

8782

2.41

145.12

3.8

2.3

53.92

71.07

u/l

1.17

1489

8046

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

504

1496

3.73

144.29

12.5

8.8

24.29

24.28

mmol/l

0.03

475

1459

(3018418) pH of Serum or Plasma

1561

8522

2.41

143.90

8.9

3.3

7.40

1.67

351

1546

(3044640) Blood type and Crossmatch panel - Blood

1611

8956

2.39

142.07

4.6

2.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

331

726

4.90

141.64

3.5

2.5

3.90

3.42

g/l

4.11

315

691

(3033658) Prothrombin time (PT) actual/Normal

1395

7291

2.44

141.22

8.2

3.5

80.23

87.68

19.51

1359

7128

(3002179) Metamyelocytes/100 leukocytes in Blood

597

2004

3.35

141.15

4.8

3.7

0.98

0.64

1.90

354

520

(3004809) Band form neutrophils/100 leukocytes in Blood

224

344

6.86

140.02

3.7

1.65

1.59

0.06

208

302

(3037756) Immunofixation for Serum or Plasma

273

515

5.63

138.61

2.1

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

195

266

7.67

135.68

1.6

1.4

—

(3019060) Gas panel - Arterial blood

569

1899

3.35

135.49

6.7

4.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

606

2102

3.24

135.45

5.0

3.9

0.11

0.05

345

516

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

349

830

4.53

135.04

5.5

3.2

75.87

59.98

mg/l

0.27

277

673

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2119

13446

2.30

134.65

4.6

2.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

349

832

4.52

134.62

5.5

3.2

75.35

122.66

mg/l

0.31

279

673

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1924

11774

2.29

132.76

4.6

2.6

217.25

131.05

ug/l

15.37

1793

10732

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

341

810

4.53

132.08

5.4

3.2

2.67

ratio

0.00

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3037

22653

2.70

132.02

16.2

6.2

92.52

77.73

u/l

33.06

2938

21185

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

218

348

6.58

131.24

1.9

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

218

348

6.58

131.24

1.9

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

203

301

7.07

131.03

1.8

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

781

3194

2.82

129.82

2.1

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

685

2616

2.97

129.19

2.1

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

355

893

4.28

127.57

2.8

2.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

169

217

8.10

123.75

3.8

—

(40758558) Short blood count panel - Blood

1321

7094

2.32

122.12

12.2

5.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

507

1675

3.34

122.10

5.3

2.8

117.66

131.40

g/l

27.79

495

1627

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

136

138

10.18

119.52

1.2

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

728

3010

2.76

117.49

5.1

2.6

10.52

8.71

umol/l

1.32

607

2645

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

487

1621

3.30

115.59

14.1

8.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

169

237

7.42

114.62

1.9

1.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

369

1031

3.86

114.45

1.4

23.17

10.38

u/ml

—

(3021589) Normoblasts [#/volume] in Blood

1979

12755

2.15

113.96

20.6

8.2

0.01

0.00

e9/l

0.32

1634

10403

(3026493) Urate [Moles/volume] in Serum or Plasma

1354

7536

2.24

113.10

4.5

2.5

1487.59

5565.65

umol/l

6.38

1214

6506

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1129

5848

2.32

111.88

2.4

1.6

2.02

1.30

mg/l

4.42

934

4390

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1263

6929

2.23

108.40

4.4

2.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

268

614

4.62

108.23

5.6

3.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

305

779

4.17

107.00

3.1

2.3

85.50

91.07

3.02

296

750

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1513

8957

2.15

106.72

2.8

2.1

240.93

221.91

u/l

0.29

1428

8373

(3025159) Blasts/100 leukocytes in Blood

542

2018

2.97

105.68

5.2

3.9

0.39

0.33

0.08

287

443

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1118

5891

2.27

105.36

5.4

3.6

392.68

671.38

ng/l

0.89

974

4790

(3037467) Urinalysis macro (dipstick) panel - Urine

2716

20125

2.23

105.08

6.5

3.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

984

4944

2.34

103.53

3.5

2.7

1.65

1.04

e6/l

2.93

572

2835

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

506

1848

3.01

101.94

14.0

8.3

0.63

0.66

0.77

500

1839

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

506

1857

2.99

101.02

13.9

8.2

1.39

1.33

0.81

500

1849

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

682

2934

2.61

100.42

6.0

2.9

—

(3011412) CD3 cells [#/volume] in Blood

140

185

7.82

99.94

2.8

2.5

1.20

1.15

e9/l

0.19

126

164

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

255

604

4.45

98.61

1.7

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

493

1832

2.94

96.00

10.2

6.0

24.44

24.50

mmol/l

0.11

466

1740

(3021901) Oxygen saturation in Capillary blood

223

485

4.82

95.82

5.0

2.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

277

720

4.07

94.68

7.1

3.7

8.20

8.49

kpa

1.63

270

704

(3015235) Bicarbonate [Moles/volume] in Capillary blood

272

699

4.11

94.42

6.0

2.8

24.29

24.91

mmol/l

1.28

264

683

(3000494) Fungus identified in Specimen by Culture

701

3154

2.50

93.42

1.8

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

914

4627

2.28

93.21

3.7

2.8

3.63

1.98

e6/l

0.80

499

2538

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

620

2634

2.62

93.16

4.4

2.6

336.26

187.25

ng/l

8.52

567

2388

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

354

1104

3.43

92.57

2.9

1.7

—

(3024928) Oxygen saturation in Venous blood

238

561

4.46

92.53

4.8

2.8

—

(3027315) Oxygen [Partial pressure] in Blood

244

591

4.34

91.59

7.0

4.0

8.38

8.50

kpa

0.46

238

579

(3013290) Carbon dioxide [Partial pressure] in Blood

243

590

4.33

90.92

7.0

4.0

4.98

5.01

kpa

0.20

237

578

(3012501) Base excess in Blood by calculation

243

590

4.33

90.92

7.0

4.0

2.60

2.67

mmol/l

0.12

176

377

(3021879) Hepatitis B virus core Ab [Presence] in Serum

451

1645

2.98

90.59

1.6

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

390

1308

3.21

90.58

5.9

2.8

25.14

25.19

mmol/l

0.08

377

1266

(1616796) Gas panel - Central venous blood

245

601

4.29

90.44

6.4

3.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1230

7072

2.09

90.44

1.8

1.5

18.87

20.31

nmol/l

2.90

1109

5954

(3022313) Gas panel - Capillary blood

399

1362

3.16

89.94

7.9

3.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

124

161

7.93

89.81

2.0

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

516

2038

2.77

89.36

7.2

3.4

136.87

82.44

ng/l

13.21

456

1735

(3019309) Folate [Moles/volume] in Red Blood Cells

1049

5709

2.16

88.82

2.1

1.7

1243.93

1157.21

nmol/l

1.73

823

4238

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

103

108

9.78

88.28

1.9

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

232

557

4.37

88.05

4.0

2.2

15.31

16.70

5.02

138

288

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

335

1045

3.42

87.44

4.2

2.1

4.18

3.60

g/l

2.69

304

925

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

335

1046

3.42

87.31

4.2

2.1

7.53

7.20

g/l

2.83

304

925

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

335

1046

3.42

87.31

4.2

2.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1737

11401

1.96

87.14

6.0

3.5

79.14

62.79

ng/l

0.27

1432

8157

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

207

458

4.72

87.03

1.7

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

151

255

6.13

85.72

1.7

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

151

255

6.13

85.72

1.7

1.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

115

145

8.15

85.35

2.6

2.3

12.94

15.06

1.05

110

139

(3010421) pH of Blood

261

700

3.93

85.28

7.1

3.7

7.42

0.14

241

631

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

326

1020

3.40

84.62

2.7

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

253

669

3.98

84.31

2.2

1.5

1.16

g/l

0.07

237

633

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

248

648

4.02

84.01

2.2

1.5

0.25

0.23

g/l

1.64

229

615

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

193

415

4.85

83.97

1.8

1.4

108.71

119.90

u/ml

0.46

(1175426) CD3 cells/100 lymphocytes in Blood

115

148

7.98

83.90

2.6

2.3

72.72

70.24

0.56

110

139

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

318

987

3.42

83.58

4.1

2.1

11.24

10.22

g/l

1.39

286

859

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

222

539

4.31

82.98

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

259

710

3.84

81.99

7.4

4.4

2.03

1.42

mg/l

13.77

237

644

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

259

712

3.83

81.66

3.3

2.5

225.19

183.11

8.23

251

677

(3024891) Influenza virus A+B Ag [Presence] in Specimen

241

630

4.02

81.56

1.3

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

242

637

3.99

81.11

1.5

1.2

5.06

11.36

iu/ml

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

9.70

79.40

2.0

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

271

789

3.62

78.50

1.6

1.5

100.00

327.74

titre

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

346

1174

3.14

78.48

7.3

4.1

1.76

1.65

1.08

323

1091

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

140

240

6.02

78.24

1.9

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

105

132

8.15

78.10

2.7

2.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

9.60

77.91

2.0

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

193

442

4.55

77.69

1.5

1.3

—

(3028271) Lactate [Moles/volume] in Capillary blood

184

407

4.70

77.32

2.9

1.6

1.68

1.70

mmol/l

0.10

179

395

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

307

979

3.32

77.14

4.3

2.1

3.18

2.82

g/l

6.35

276

859

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

132

217

6.27

76.95

1.9

1.7

—

(3010375) cycloSPORINE [Mass/volume] in Blood

9.99

76.77

35.9

24.2

118.21

124.72

ug/l

0.29

(3015377) Calcium [Moles/volume] in Serum or Plasma

1512

9780

1.91

76.36

5.2

3.0

2.33

2.36

mmol/l

11.66

1340

8461

(3036489) Thrombin time

306

980

3.31

76.34

2.9

2.1

22.14

21.70

0.54

277

873

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

175

379

4.79

75.43

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

287

899

3.37

74.16

4.3

2.3

2.43

1.02

g/l

2.26

243

750

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

344

1211

3.02

73.07

8.0

3.7

24.75

24.69

mmol/l

0.12

323

1117

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

182

418

4.52

72.97

1.5

1.3

264.52

246.96

u/ml

0.28

118

247

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

552

2477

2.44

72.67

3.3

2.2

35.33

37.55

u/l

0.26

469

2127

(3007930) Methemoglobin/Hemoglobin.total in Blood

334

1164

3.05

72.19

7.6

4.2

0.85

0.89

0.97

314

1081

(3021788) Differential panel - Synovial fluid

183

426

4.46

72.12

1.9

1.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

100

131

7.81

71.84

3.0

2.6

0.21

0.22

e9/l

0.19

113

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

101

137

7.55

70.41

3.0

2.6

584.52

456.19

e6/l

1.41

114

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1788

12432

1.83

69.92

2.5

1.9

91.69

94.35

pmol/l

1.64

1083

6476

(3042733) HLA Ab [Presence] in Serum

11.26

69.31

4.7

4.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

236

683

3.62

68.85

1.6

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

141

275

5.29

68.61

3.3

2.4

1.71

1.50

g/24h

0.24

131

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

331

1207

2.91

65.83

5.3

3.3

49.89

47.87

0.71

323

1191

(3003434) Protein [Mass/volume] in Pleural fluid

168

394

4.42

65.55

1.5

1.4

30.97

32.52

g/l

0.71

139

355

(3037522) Nuclear Ab [Titer] in Serum

653

3294

2.19

64.74

1.5

1.3

498.84

519.83

titre

0.10

138

689

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

257

819

3.29

64.44

3.8

2.0

35.49

38.52

g/l

9.67

226

699

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1657

11455

1.79

64.34

3.0

2.1

75.39

77.82

nmol/l

2.87

1500

10108

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

224

655

3.57

64.29

1.6

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

120

217

5.68

63.40

3.7

3.1

59.74

53.48

1.95

109

180

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2206

16641

1.78

62.84

3.3

2.7

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

187

491

3.95

62.74

4.6

3.5

60.37

56.77

2.32

187

491

(3035350) Ketones [Presence] in Urine by Test strip

1933

14050

1.77

62.54

5.2

3.4

0.00

estimate

0.15

488

2762

(3007164) IgA [Mass/volume] in Serum or Plasma

882

5036

1.98

62.36

2.1

1.4

2.75

2.42

g/l

3.17

645

2907

(3023199) Leukocytes [#/volume] in Pleural fluid

155

355

4.51

62.31

1.5

1.4

7554.48

1967.40

e6/l

0.44

109

260

(3013707) Erythrocyte sedimentation rate by Westergren method

2690

21606

1.84

61.06

6.2

3.7

23.04

11.33

mm/h

116.40

2533

19792

(3048929) Epstein Barr virus Ab [Presence] in Serum

229

705

3.39

60.65

1.5

1.3

—

(3047181) Lactate [Moles/volume] in Blood

272

933

3.06

60.21

8.6

4.8

1.40

1.32

mmol/l

0.62

236

825

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

242

775

3.27

60.14

4.1

2.0

0.06

0.05

g/l

0.12

227

698

(3009261) Glucose [Presence] in Urine by Test strip

1939

14214

1.74

59.91

5.2

3.4

0.00

estimate

0.80

440

2499

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

157

6.45

59.76

1.5

1.6

—

(3044941) Cell count panel - Synovial fluid

163

401

4.20

59.74

1.8

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

1918

14032

1.74

59.55

6.8

4.6

0.00

estimate

0.50

461

2586

(3026250) Tacrolimus [Mass/volume] in Blood

9.06

59.36

39.3

34.0

7.18

7.71

ug/l

0.75

(3000475) Leukocytes [#/volume] in Synovial fluid

208

614

3.53

58.79

1.9

1.5

42209.12

12613.64

e6/l

3.05

142

443

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

227

713

3.32

58.20

4.2

2.1

0.00

g/l

-0.00

213

651

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

229

726

3.29

57.83

4.2

2.0

0.00

g/l

0.23

214

652

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3371

29439

2.29

57.40

44.0

11.7

40.16

23.48

mg/l

97.78

3167

22850

(3042111) Morphology [Interpretation] in Bone marrow Narrative

172

456

3.90

56.90

2.4

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

552

2740

2.19

56.42

2.8

2.3

8.31

8.03

ug/l

0.08

481

2400

(3007566) Smooth muscle Ab [Titer] in Serum

208

631

3.43

56.34

1.2

75.71

101.56

titre

0.50

(3015736) pH of Urine

1599

11249

1.73

56.03

4.6

3.2

5.67

5.81

0.43

719

(3006184) Hemoglobin [Mass/volume] in Capillary blood

212

654

3.37

55.92

3.2

2.0

122.87

132.01

g/l

5.41

170

456

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

104

187

5.69

55.27

1.9

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

104

187

5.69

55.27

1.9

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

104

187

5.69

55.27

1.9

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

125

265

4.84

55.22

3.7

2.1

—

(3000012) Reticulocyte production index

161

416

4.00

55.20

2.5

1.9

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2336

18311

1.72

54.19

5.4

2.9

82.14

47.40

u/l

25.09

2190

16879

(3052851) Hemolysis interference index of Serum or Plasma

240

816

3.07

53.86

5.2

2.8

—

(3017704) Immunofixation for Urine

126

6.79

53.46

2.2

1.5

—

(3012441) Differential panel - Pleural fluid

131

297

4.53

53.32

1.5

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

108

209

5.29

52.99

1.3

1.2

—

(3045788) Cell count panel - Pleural fluid

125

275

4.67

52.81

1.6

1.4

—

(3006245) CD3-CD19+ cells/100 cells in Blood

8.62

52.45

3.1

2.8

12.02

13.58

0.22

(3028308) Erythrocytes [#/volume] in Pleural fluid

137

326

4.32

52.43

1.5

1.4

85859.21

61037.52

e6/l

0.34

195

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

133

6.51

51.97

1.7

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

130

6.59

51.90

1.7

1.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

100

185

5.52

51.55

1.2

1.1

—

u/ml

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

475

2298

2.22

51.48

2.7

2.2

371.95

373.79

nmol/l

0.05

446

2087

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

109

220

5.07

51.00

2.5

2.4

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

8.78

50.88

2.9

2.3

34.37

26.32

2.89

(3018405) Lactate [Moles/volume] in Arterial blood

270

1013

2.79

50.65

5.7

3.6

1.44

1.37

mmol/l

0.43

264

1005

(3009508) Creatinine [Moles/volume] in Urine

1404

9749

1.70

50.06

4.3

3.1

6.66

7.84

mmol/l

19.68

1185

8161

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

142

361

4.05

49.77

1.3

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

8.17

49.53

1.2

1.1

325.31

169.22

iu/ml

1.69

(3039000) Anion gap in Blood

202

653

3.21

49.33

9.8

5.4

11.68

11.28

mmol/l

0.78

184

578

(3018572) Chloride [Moles/volume] in Blood

202

654

3.21

49.21

9.8

5.4

104.05

105.23

mmol/l

2.37

184

579

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

7.54

48.35

1.8

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

7.54

48.35

1.8

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

196

634

3.21

47.81

1.2

533.33

1313.53

titre

—

(3025941) Bacteria identified in Stool by Culture

321

1357

2.49

47.28

1.4

1.2

—

(3023419) Bacteria identified in Sputum by Culture

146

393

3.82

47.25

2.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

106

224

4.84

47.01

4.5

2.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

107

229

4.78

46.74

1.4

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

173

529

3.38

46.22

1.6

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

123

6.37

46.15

2.4

2.8

38.64

39.58

0.13

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

9.15

46.02

1.9

1.7

1629.17

5956.17

u/ml

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

139

369

3.87

45.88

1.7

0.82

0.84

g/l

0.05

299

(3024471) HLA-A [Type]

8.34

45.80

1.0

—

(3042631) Mycobacterium sp identified in Specimen

134

348

3.95

45.61

2.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

548

2926

2.02

45.53

3.7

3.9

28.35

18.72

ug/l

0.30

447

2404

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

7.16

44.89

2.1

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

7.16

44.89

2.1

1.8

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

105

230

4.67

44.60

1.4

8.74

6.55

g/l

1.71

173

(3024932) HLA-DR beta [Type]

8.19

44.43

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

101

215

4.80

44.41

1.4

1.1

66.05

64.48

u/l

0.05

189

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

130

6.02

43.69

1.4

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

130

6.02

43.69

1.4

1.6

—

(4062490) Immunoglobulin typing, IgG

104

230

4.62

43.66

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

104

230

4.62

43.66

1.5

1.4

2.56

3.09

g/l

1.39

171

(3024139) IgG subclass 3 [Mass/volume] in Serum

104

230

4.62

43.66

1.5

1.4

0.42

0.40

g/l

0.10

172

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

153

449

3.51

43.58

1.2

—

77.14

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

119

294

4.15

43.35

2.0

1.4

73.89

59.26

3.92

174

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

102

6.77

43.28

3.2

3.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

180

588

3.16

43.17

3.2

0.80

0.81

nmol/l

0.05

135

451

(3020682) Albumin/Creatinine [Ratio] in Urine

1366

9706

1.64

42.84

4.9

3.7

27.51

7.24

mg/mmol

11.29

980

6147

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

105

242

4.43

41.87

1.1

—

(3012516) Albumin [Mass/volume] in Urine

1308

9248

1.63

41.54

4.4

3.2

742.23

271.64

mg/l

2.37

956

5918

(3020891) Body temperature

276

1154

2.50

41.51

7.7

4.2

—

(40768806) Pleura Pathology biopsy report

119

305

4.00

41.25

1.4

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

144

431

3.43

39.79

1.3

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

8.72

39.63

3.2

2.6

822.14

309.63

e6/l

0.34

(4035726) Immunohistochemistry procedure

447

2327

2.04

39.53

1.7

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

7.74

39.51

2.2

2.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

109

271

4.11

39.39

1.2

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

181

4.84

38.35

1.1

1.3

320.00

186.36

titre

0.48

(3016650) Hepatitis A virus Ab [Presence] in Serum

130

377

3.54

37.71

1.2

1.0

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

+∞

37.56

5.3

0.0

1.36

—

mg/l

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

130

380

3.51

37.26

1.1

1.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

7.45

36.89

2.2

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

7.45

36.89

2.2

2.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

442

2349

2.00

36.78

9.7

3.1

1.21

1.23

mmol/l

4.09

411

2009

(21494814) CD8 cells/100 lymphocytes in Specimen

7.35

36.44

2.1

2.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

7.78

36.13

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

7.66

35.67

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

104

6.04

35.43

1.3

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

105

275

3.90

35.35

3.4

3.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

147

5.11

35.29

1.3

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

106

285

3.80

34.39

1.3

6.37

6.49

mmol/l

0.13

264

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

130

401

3.32

34.26

1.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

124

5.40

33.50

1.5

1.1

31.90

15.77

u/l

1.77

102

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

526

3050

1.84

33.46

2.3

1.7

1.68

1.50

4.14

441

2672

(3037121) Protein [Mass/volume] in Urine

230

978

2.44

33.27

4.1

3.3

0.51

0.27

g/l

3.83

134

388

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

130

5.23

32.82

1.5

1.1

118.42

82.94

u/l

1.14

108

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

120

362

3.39

32.77

2.9

2.6

29.96

1214.94

u/ml

0.86

114

356

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

227

4.08

32.77

1.7

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

6.26

32.58

3.7

2.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

932

6370

1.61

32.42

1.9

1.7

53088522.13

31108972.57

pmol/l

0.37

761

5214

(3047189) Immunofixation for 24 hour Urine

117

5.46

32.39

2.7

1.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3375

30758

1.87

32.19

47.1

14.6

138.83

139.73

mmol/l

67.44

3322

29928

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

8.32

32.10

1.6

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

8.04

31.98

2.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

102

281

3.70

31.96

1.2

1.3

963.65

327.69

u/l

0.71

267

(40768446) Kidney Pathology biopsy report

6.42

31.58

2.2

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

12.49

31.51

1.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3375

30833

1.85

30.87

47.9

14.7

4.00

3.99

mmol/l

1.58

3314

29953

(40761536) Microorganisms panel - Urine sediment

429

2390

1.90

30.82

6.8

3.6

—

(21494434) Karyotype in Bone marrow

236

3.88

30.28

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

100

5.67

30.02

5.6

3.8

53.85

74.70

mg/l

1.74

(3023487) Leukocytes [#/volume] in Peritoneal fluid

6.56

29.79

2.6

1.9

883.39

10021.24

e6/l

0.48

(3051651) Icteric interference index of Serum or Plasma

150

4.67

29.64

5.5

2.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

950

6646

1.57

29.51

4.5

3.4

—

(3002385) Erythrocyte distribution width [Ratio]

2873

25282

1.56

29.19

46.0

14.8

15.47

14.98

5.48

2836

24778

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

103

306

3.43

28.83

1.9

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

101

298

3.45

28.58

1.9

1.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

11.19

28.45

7.2

6.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

101

299

3.44

28.43

1.9

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

101

300

3.43

28.29

1.9

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

100

298

3.42

27.87

1.9

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

106

328

3.30

27.83

7.9

24.7

7.66

7.18

mmol/l

0.62

271

(3045142) Bone marrow Pathology biopsy report

294

3.43

27.74

1.6

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

101

304

3.39

27.71

1.9

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

179

741

2.49

27.42

1.7

1.5

0.11

13.78

iu/ml

0.97

149

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

795

5427

1.59

27.13

4.0

2.9

2.48

2.45

mmol/l

7.55

680

4737

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

125

4.86

27.13

1.8

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1033

7500

1.52

26.65

5.3

3.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

126

443

2.91

26.61

8.3

2.8

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

235

3.68

26.54

2.2

1.4

21.47

27.88

1.09

140

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

175

4.12

26.03

2.9

1.8

—

(3013512) EKG study

1176

8814

1.48

25.83

5.7

3.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1403

10891

1.46

25.70

5.9

3.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

231

1098

2.18

25.69

1.9

1.8

38.39

39.42

u/l

0.31

201

962

(3003181) Sodium [Moles/volume] in Urine

128

463

2.83

25.67

1.6

1.4

59.54

65.23

mmol/l

0.73

376

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

6.57

25.54

2.5

2.0

5382.20

6390.47

e6/l

0.13

(3029937) Albumin [Presence] in Urine by Test strip

1050

7706

1.50

25.52

6.2

3.7

0.00

estimate

0.24

403

2489

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

159

646

2.53

25.35

2.2

1.9

12.26

10.96

mg/l

0.91

143

597

(3028433) Virus identified in Specimen by Culture

6.11

24.99

1.3

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

241

3.54

24.84

1.6

1.2

64835.39

165091.98

e6/l

0.84

167

(3029634) Reagin Ab [Titer] in Serum by VDRL

102

332

3.13

24.67

2.1

1.9

2.67

4.50

titre

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

260

3.40

24.17

1.2

1.1

—

(3019977) pH of Arterial blood

146

4.30

24.14

2.2

2.7

7.41

7.43

0.45

(3033799) Differential panel - Peritoneal fluid

6.31

23.98

2.7

1.7

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

223

3.60

23.95

1.1

1.3

17.96

14.47

u/l

0.25

204

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

9.12

23.84

2.9

2.8

26.64

17.12

mg/l

—

(3035880) pH of Pleural fluid

169

4.02

23.83

1.3

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

296

3.20

23.37

1.2

1.1

—

(40768441) Liver Pathology biopsy report

160

4.05

23.05

2.0

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

8.01

23.01

2.6

1.9

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

5.73

22.87

1.1

1.5

—

(3017732) Neutrophils [#/volume] in Blood

324

1811

1.86

22.82

4.1

2.9

5.85

5.93

e9/l

0.03

235

1425

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

158

4.04

22.60

1.6

1.2

—

(40768797) Stomach Pathology biopsy report

590

3908

1.60

22.45

1.3

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

168

746

2.31

22.03

2.7

1.6

—

(3051611) Lipemic interference index of Serum or Plasma

272

3.21

21.85

5.0

2.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

102

357

2.91

21.77

1.2

1.1

1.63

1.50

g/l

1.89

316

(3044007) Cell count panel - Peritoneal fluid

5.99

21.67

2.5

1.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

208

1016

2.11

21.57

3.2

334.43

4329.91

u/ml

0.85

174

878

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

197

3.60

21.35

1.2

1.3

—

(3044927) Protein electrophoresis panel - Urine

277

3.15

21.21

1.3

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

5.81

21.01

10.0

6.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

132

4.21

20.93

2.0

1.5

6.02

7.10

u/l

0.21

107

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

5.72

20.68

1.3

1.1

—

(40761511) CBC panel - Blood by Automated count

3300

30594

1.60

20.64

36.8

11.9

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

6.52

20.45

2.1

1.5

14.29

14.85

g/l

0.09

(3008037) Lactate [Moles/volume] in Venous blood

144

621

2.37

20.21

4.3

2.7

1.74

1.71

mmol/l

0.11

138

602

(3002256) Pathology report gross observation

569

3825

1.57

20.17

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

5.85

20.08

3.2

2.8

—

(3052592) Norovirus Ag [Presence] in Stool

6.79

19.95

1.3

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

7.02

19.92

1.4

1.1

23.74

29.19

g/l

0.68

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

5.24

19.83

10.2

6.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

126

517

2.49

19.73

1.5

1.2

58.05

32.67

u/l

1.02

119

444

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

199

3.46

19.57

1.0

1.1

—

(3044889) 12 lead EKG panel

2387

20958

1.37

18.87

5.6

3.8

—

(3004451) EKG impression Narrative

126

4.09

18.71

1.4

1.2

—

(40768443) Skin Pathology biopsy report

233

1248

1.92

18.67

1.3

1.2

—

(3011288) Drugs identified in Urine by Screen method

123

515

2.43

18.45

5.6

2.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

134

3.92

18.03

3.3

3.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

207

3.28

17.74

1.7

1.3

1.57

1.17

promille

0.98

163

(3003694) ABO and Rh group [Type] in Blood

1020

7878

1.40

17.69

1.5

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

132

3.90

17.58

1.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

132

3.90

17.58

1.0

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

115

4.13

17.48

1.2

1.3

49.86

64.62

1.50

(3011648) Oxygen content in Venous blood

225

3.15

17.38

2.8

10.07

11.11

1.31

225

(3019225) pH of Specimen

454

2996

1.59

17.28

9.4

3.5

—

(3016750) Collection duration of Urine

176

3.45

17.25

2.6

1.9

520.43

491.38

min

1.02

121

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3356

31484

1.57

17.13

44.7

14.7

97.93

79.61

umol/l

34.77

3356

31474

(3036525) Urea [Moles/time] in 24 hour Urine

31.60

17.02

2.8

3.3

—

(3028707) Methadone [Presence] in Urine by Screen method

338

2.70

16.91

5.5

2.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

145

3.69

16.91

1.1

—

(40768804) Tissue Pathology biopsy report

1417

11609

1.35

16.85

2.4

2.1

—

(40757373) Influenza virus identified in Isolate

6.08

16.84

1.4

1.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

6.26

16.73

1.9

1.1

—

(3014271) Vancomycin [Susceptibility]

143

3.67

16.47

3.3

2.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

263

1523

1.78

16.44

1.4

1.3

187.38

225.25

u/ml

0.55

236

1408

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

369

2348

1.63

16.30

3.4

2.4

51.02

66.31

ml/min/173m2

10.01

188

921

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3347

31446

1.54

16.24

21.4

9.3

27.15

26.37

u/l

1.19

3265

30128

(3000570) Elastase.pancreatic [Mass/mass] in Stool

159

784

2.07

16.12

1.4

1.5

246.14

283.85

ug/g

1.24

466

(3030981) Hyaline casts [#/volume] in Urine by Automated count

267

1567

1.76

15.94

4.1

2.5

0.41

0.25

e6/l

1.12

260

1534

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3000

27626

1.41

15.92

35.4

12.1

74.15

78.74

ml/min/173m2

16.93

2661

22506

(3014765) Yersinia sp identified in Stool by Organism specific culture

157

776

2.07

15.82

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

156

770

2.07

15.78

1.3

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

129

3.76

15.73

1.2

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

5.61

15.54

6.8

7.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

108

4.02

15.47

3.2

2.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

109

469

2.36

15.45

1.7

1.2

—

(3017569) Oxygen content in Arterial blood

140

3.61

15.44

1.8

2.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

157

784

2.05

15.40

1.3

1.2

—

(40768795) Lymph node Pathology biopsy report

226

3.00

15.37

1.3

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

127

3.73

15.29

1.8

1.5

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

120

3.78

14.92

1.8

1.3

2.50

7.41

1.29

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

373

2.50

14.85

1.5

1.2

3.71

3.27

u/ml

0.14

125

(3033705) Calcium.ionized [Moles/volume] in Venous blood

332

2.60

14.82

3.6

2.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

140

3.53

14.70

1.2

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

146

3.46

14.52

1.7

2.3

—

(3004775) Volume in Urine collected for unspecified duration

242

2.84

14.20

2.7

2.1

762.93

607.34

1.62

150

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2418

21701

1.31

14.03

4.1

3.7

14.81

14.85

pmol/l

0.31

2173

19470

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

126

3.60

13.93

1.1

1.2

1.08

1.05

ratio

0.40

(3044290) Cell count panel - Cerebral spinal fluid

115

530

2.21

13.90

2.3

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

292

1824

1.65

13.85

1.8

1.7

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

258

2.75

13.70

1.1

1.2

1.50

1.51

nmol/l

0.03

226

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

13.60

13.70

1.3

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

171

918

1.90

13.65

1.3

1.2

0.38

0.67

u/ml

0.75

(3032352) Blasts [#/volume] in Cerebral spinal fluid

12.07

13.56

4.8

2.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

10.06

13.44

1.1

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

126

611

2.10

13.40

5.1

1.9

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

116

548

2.15

13.20

3.3

2.9

373.88

596.23

u/ml

0.30

109

502

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

121

584

2.11

13.04

1.9

1.3

3.95

3.74

mmol/l

0.89

115

543

(3036180) Methadone [Presence] in Urine

4.10

13.00

2.3

1.6

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

5.23

12.95

3.5

3.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

119

573

2.11

12.91

2.4

1.4

148.59

11.57

e6/l

1.42

448

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

119

573

2.11

12.91

2.4

1.4

985.73

1064.03

e6/l

0.04

100

471

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

184

1033

1.82

12.78

5.1

3.1

49.02

58.62

u/ml

0.38

179

992

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2897

26812

1.34

12.69

5.0

4.4

2.03

2.14

mu/l

0.49

2648

24201

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

192

2.95

12.54

1.6

1.5

31.18

24.50

u/ml

0.28

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

17.35

12.50

1.8

1.5

5.01

2.99

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

17.35

12.50

1.8

1.5

0.82

0.54

mg/l

—

(44786800) Granulocytes/100 leukocytes in Body fluid

6.21

12.46

1.3

1.4

28.77

18.01

0.53

(40761535) Cells panel - Urine sediment

365

2469

1.53

12.32

4.9

3.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

141

737

1.95

12.22

2.9

2.2

189.74

112.26

ug/min

0.97

427

(3014891) Appearance of Pleural fluid

6.03

12.12

1.2

1.1

—

(3016038) Potassium [Moles/volume] in Urine

175

3.00

12.05

1.6

1.2

31.62

35.72

mmol/l

0.64

155

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

102

3.65

11.76

1.5

2.0

177.97

146.56

1.27

(3009871) Measles virus Ab [Titer] in Serum

4.35

11.68

1.7

1.6

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

16.44

11.65

1.4

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

270

2.55

11.55

2.1

1.4

—

(3008295) Osmolality of Serum or Plasma

283

2.50

11.45

1.2

1.4

280.42

279.43

mosm/kgh2o

0.10

214

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

345

2.35

11.38

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

123

629

1.99

11.38

1.3

1.2

7.88

7.28

u/ml

0.06

102

(3023383) Lactate [Moles/volume] in Pleural fluid

3.93

11.27

1.3

1.2

2.16

3.46

mmol/l

2.27

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

223

2.67

11.07

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

131

3.23

11.07

1.4

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

128

672

1.94

10.99

1.3

1.2

31.91

45.47

u/ml

0.34

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

15.51

10.81

1.4

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

5.14

10.78

2.6

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

3433

32861

1.47

10.70

57.9

18.5

37.35

40.71

42.21

3173

30528

(3000492) Spirometry study

380

2668

1.47

10.69

1.7

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.85

10.64

2.6

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.85

10.64

2.6

2.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

248

1590

1.60

10.60

2.7

2.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

350

2.28

10.59

4.6

4.3

364.14

352.64

umol/l

0.33

300

(21494755) Public health laboratory ask at order entry panel

116

2139

0.53

10.58

1.2

1.4

—

(3007461) Platelets [#/volume] in Blood

3433

32878

1.46

10.49

57.1

18.4

239.53

243.51

e9/l

2.29

3377

31899

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

119

621

1.95

10.41

1.3

1.2

2.56

2.90

u/ml

0.12

(3010813) Leukocytes [#/volume] in Blood

3434

32896

1.46

10.41

57.0

18.4

7.51

6.75

e9/l

22.47

3366

31795

(3016879) Cocaine [Presence] in Urine

136

743

1.86

10.36

5.2

1.9

—

(3026389) Candida sp identified in Specimen by Organism specific culture

322

2.32

10.35

1.4

—

(3024731) MCV [Entitic volume]

3433

32892

1.45

10.32

56.9

18.4

91.58

91.13

5.58

3395

32332

(3035941) MCH [Entitic mass]

3433

32893

1.45

10.31

56.8

18.3

30.22

30.40

5.81

3395

32333

(3001893) Eosinophils/100 leukocytes in Pleural fluid

3.53

10.30

1.2

1.4

1.27

3.28

1.29

(3026361) Erythrocytes [#/volume] in Blood

3433

32896

1.45

10.28

57.0

18.4

4.17

4.52

e12/l

201.24

3367

31797

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.82

10.20

1.1

1.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

3433

32905

1.45

10.17

57.5

18.5

124.23

136.70

g/l

293.11

3392

32353

(3048879) Bone marrow aspiration report

3.77

10.03

2.0

1.8

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.97

10.02

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

4.80

10.00

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

3.67

9.96

1.2

1.3

35.85

20.26

1.65

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

361

2.21

9.86

1.5

1.2

5.38

4.44

u/ml

0.28

157

(3000764) Benzodiazepines [Presence] in Urine

142

799

1.81

9.86

5.1

1.9

—

(3027008) Opiates [Presence] in Urine

142

806

1.79

9.59

5.0

1.9

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

100

506

2.00

9.59

1.4

1.2

1.09

5.70

u/ml

0.64

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

3.93

9.57

1.1

—

(3019150) Specific gravity of Urine by Refractometry

785

6314

1.31

9.54

5.9

3.8

1.02

kg/l

0.78

121

956

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

123

3.11

9.47

2.6

36413.16

41537.75

ug/l

1.58

123

(3028300) Cannabinoids [Presence] in Urine

142

810

1.78

9.44

5.3

1.8

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

4.12

9.43

2.2

2.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

109

573

1.93

9.37

1.7

1.6

1.12

0.80

nmol/l

1.49

479

(3049717) Cytology report of Urine Cyto stain

206

1302

1.62

9.36

2.8

2.7

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

299

2.30

9.32

4.6

3.6

44.03

34.19

u/ml

0.29

290

(3025549) Creatine [Moles/time] in 24 hour Urine

10.67

9.27

1.4

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

160

2.77

8.95

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

160

2.77

8.95

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

160

2.77

8.95

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

162

2.74

8.76

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

198

2.55

8.63

1.3

1.4

14.00

12.97

umol/l

0.39

184

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.39

8.61

1.5

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.81

8.50

1.3

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

198

1272

1.59

8.44

1.4

1.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

7.86

8.35

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

122

2.97

8.34

1.4

1.2

139.97

139.03

nmol/l

0.03

122

(3027944) Amphetamines [Presence] in Urine

135

791

1.73

8.22

5.1

1.8

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

162

2.67

8.21

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

162

2.67

8.21

1.0

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.21

8.20

1.3

3.4

55.50

190.98

umol/l

3.40

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

111

615

1.83

8.17

1.1

1.3

158.93

230.27

miu/ml

0.98

272

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

140

2.80

8.16

1.2

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

3.58

8.11

1.4

1.3

36.37

23.97

0.77

(3007463) Buprenorphine [Presence] in Urine

17.19

8.07

11.0

2.4

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

11.70

8.06

5.4

5.2

1.31

1.01

mg/l

—

(4281824) Cell count and differential, peritoneal fluid

217

2.42

8.06

1.3

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.31

8.06

1.6

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

3.15

7.94

1.1

1.2

—

(3002619) Bacteria identified in Specimen by Culture

4.27

7.93

1.5

1.1

—

(3022145) Colonoscopy Study observation

423

3195

1.36

7.83

1.5

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

9.41

7.77

4.0

4.7

—

(3042517) Benzodiazepines panel - Urine

9.41

7.77

3.7

1.4

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

15.04

7.71

1.2

1.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

3.44

7.66

1.5

1.2

14.24

34.38

3.31

(3036670) Protein [Mass/volume] in Synovial fluid

3.44

7.66

1.5

1.1

43.05

41.79

g/l

0.16

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

157

2.63

7.61

1.2

1.3

—

56.67

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.94

7.15

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

199

2.38

7.10

1.1

1.0

291.95

280.19

mg/l

0.50

176

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

109

629

1.75

7.06

2.1

2.2

3158.61

3942.61

u/l

0.19

239

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

8.78

7.04

6.9

2.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

114

668

1.73

7.00

1.3

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

717

5916

1.26

6.90

1.3

3.25

1.81

u/ml

1.01

171

1511

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

472

1.86

6.90

1.3

1.2

46.38

40.75

u/ml

0.12

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.97

6.88

1.2

1.1

93.86

80.87

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2882

27292

1.23

6.84

7.9

5.8

42.86

39.94

mmol/mol

32.73

2676

25022

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

126

2.71

6.75

2.0

1.3

50.22

68.20

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

216

1491

1.48

6.67

3.5

3.4

4.36

4.57

pmol/l

1.61

193

1288

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

6.42

6.62

1.8

2.3

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

4.01

6.62

1.2

1.1

1.76

2.86

mmol/l

—

(3023410) Appearance of Cerebral spinal fluid

264

2.14

6.60

2.7

1.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.26

6.54

1.2

1.1

79.33

83.74

0.34

(1761482) Bacteria [#/volume] in Urine by Culture

123

750

1.66

6.54

5.0

3.8

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.84

6.50

1.1

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

6.18

6.45

2.0

2.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

14.32

6.39

5.5

6.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1089

0.50

6.37

1.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

216

2.24

6.35

4.3

2.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.59

6.31

2.3

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.90

6.30

1.1

1506.54

1598.27

miu/ml

0.18

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

5.95

6.29

1.0

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

120

2.68

6.24

2.1

1.3

19.16

23.80

umol/l

0.42

115

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1449

0.57

6.17

1.3

1.4

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

6.27

6.15

3.8

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

3.21

6.14

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

5.73

6.13

2.0

2.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.76

6.08

1.4

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

5.54

5.98

1.0

1.1

12.15

25.24

u/l

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

144

2165

0.65

5.96

1.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

106

2.75

5.94

1.2

1.1

—

(1761868) Lipid panel - Serum or Plasma

825

9614

0.82

5.92

3.3

2.9

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

3.69

5.91

1.1

71.83

85.33

—

(40765096) Chromosome analysis panel by Banding

3.05

5.91

1.3

1.1

—

(3000330) Specific gravity of Urine by Test strip

210

1480

1.44

5.86

4.5

3.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.79

5.83

1.2

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

440

1.81

5.83

1.1

20.67

87.14

iu/ml

1.32

105

(3039162) Centromere protein B Ab [Units/volume] in Serum

285

2.02

5.80

1.5

1.3

38.14

50.64

u/ml

—

(4200892) Spirometry reversibility

280

2083

1.37

5.72

1.5

1.4

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

3.91

5.71

1.3

1.1

38.70

129.28

u/l

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

144

946

1.54

5.67

1.6

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

4.74

5.60

1.4

1.2

70.30

73.09

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.94

5.56

1.2

58.52

527.57

ug/l

0.75

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

8.48

5.55

3.5

3.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

529

4320

1.26

5.50

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.86

5.42

1.6

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

356

1.87

5.41

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

245

2.05

5.39

2.8

2.3

—

(3029075) Extractable nuclear Ab panel - Serum

3.19

5.31

1.1

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

11.27

5.29

1.1

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.98

5.25

1.3

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.98

5.25

1.3

80.23

78.97

0.07

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.59

5.17

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

7.35

5.14

1.3

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.80

5.13

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.85

5.11

1.1

1.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

197

2.14

5.09

1.2

1.1

6.29

2.20

u/ml

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

13.36

5.07

10.1

5.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

13.36

5.07

6.8

4.8

456.75

341.50

umol/l

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

5.67

5.06

1.2

1.0

—

(3045414) Leukocytes [Presence] in Urine

176

1240

1.44

4.96

2.1

1.8

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

3.22

4.89

1.3

1.1

1.32

1.68

mmol/l

0.90

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

130

2.40

4.88

4.4

5.8

30.43

60.90

u/ml

—

(40758292) HTLV I+II Ab panel - Serum

4.56

4.86

1.5

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

7.71

4.84

1.1

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

9.02

4.78

1.2

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

9.02

4.78

1.2

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

536

4455

1.24

4.75

1.3

1.2

42.30

33.01

iu/ml

0.77

172

1389

(3004616) Nuclear Ab [Presence] in Serum

314

1.86

4.75

1.4

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

4.68

4.67

1.9

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

178

2.15

4.65

1.5

1.3

2.57

2.07

u/ml

0.11

102

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

14.02

4.57

5.4

3.0

—

(3045424) Erythrocytes [Presence] in Urine

467

1.68

4.56

1.5

—

(3024263) Appearance of Synovial fluid

141

2.28

4.54

1.6

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.83

4.49

1.5

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

682

0.48

4.45

1.6

1.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.83

4.38

1.2

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.83

4.38

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.34

4.32

2.6

1.5

217.27

150.12

ng/l

0.32

(3035637) Corticotropin [Mass/volume] in Plasma

332

1.79

4.30

1.6

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

164

2.14

4.30

1.4

1.04

1.17

nmol/l

0.23

127

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

11.68

4.27

1.0

1.43

0.83

u/field

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

438

1.68

4.26

1.7

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.49

4.24

1.2

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

105

691

1.53

4.20

1.6

1.4

11.35

8.49

u/l

1.45

556

(3010838) Calcium [Moles/time] in 24 hour Urine

443

1.66

4.09

1.7

1.9

3.75

4.93

mmol/24h

2.73

384

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.63

4.06

1.3

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

142

2.19

4.04

1.6

1.5

—

(36660697) Celiac disease serology panel - Serum

273

2136

1.30

4.03

1.2

—

(40763590) HLA-DQ beta [Type]

10.02

4.01

1.1

1.0

—

(46236302) HLA-C [Type] by High resolution typing

10.02

4.01

1.1

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

10.02

4.01

6.1

5.3

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

10.02

4.01

7.3

5.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.94

4.00

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.68

3.98

1.3

1.1

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

6.44

3.98

1.1

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

100

660

1.53

3.97

1.2

1.1

—

(3034426) Prothrombin time (PT)

2.60

3.97

1.6

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.03

3.96

1.0

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

498

4186

1.22

3.96

1.3

1.2

11.19

11.73

u/ml

0.05

153

1619

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

165

2.07

3.85

1.7

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

6.01

3.81

1.2

1.1

—

(3003338) MCHC [Mass/volume]

2596

24795

1.15

3.80

49.7

16.4

329.47

333.01

g/l

57.20

2568

24571

(3020491) Glucose [Moles/volume] in Blood

222

1.90

3.77

3.3

1.7

8.27

6.65

mmol/l

2.41

144

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

12.02

3.76

9.3

9.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

160

2.07

3.76

2.8

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

168

2.03

3.69

1.7

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.54

3.62

1.4

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.30

3.51

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

10.01

3.49

1.2

1.0

—

(3034988) Calcium [Moles/volume] in Capillary blood

2.66

3.39

6.2

2.1

1.19

1.18

mmol/l

0.05

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

7.01

3.36

1.4

1.3

—

(40760410) HLA-B [Type] by High resolution

8.58

3.26

1.2

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

8.58

3.26

1.0

—

(3013862) HLA-DP [Type]

8.58

3.26

1.2

1.0

—

(40760409) HLA-A [Type] by High resolution

8.58

3.26

1.2

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.67

3.22

1.1

1.6

2076.50

182.55

nmol/24h

0.44

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

6.37

3.18

1.1

1.0

—

(3048689) Calprotectin [Mass/mass] in Stool

377

3154

1.22

3.16

2.3

2.2

185.86

140.64

ug/g

1.09

305

2468

(3004446) Plasmodium sp identified in Blood by Light microscopy

4.51

3.11

3.0

2.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.01

3.08

1.9

2.0

51.90

37.08

umol/l

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

415

1.58

3.06

1.7

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

195

1.85

3.06

1.3

1.1

126.87

44.75

mg/l

0.70

161

(3043410) Blood group antigens tested for on Red Blood Cells

2.38

3.05

2.8

1.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.69

3.05

1.3

1.4

0.32

ug/l

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

7.51

3.05

1.2

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.44

3.04

1.3

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

5.84

3.02

24.6

3.6

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

4.29

2.99

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

10.01

2.98

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

10.01

2.98

1.2

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.25

2.93

1.2

—

(3011985) Renin [Units/volume] in Plasma

343

1.61

2.88

1.4

1.3

56.12

66.65

mu/l

0.27

300

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

6.67

2.86

2.2

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

187

1.83

2.78

1.2

1.1

563.52

297.44

mg/l

0.60

163

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

8.34

2.75

5.6

3.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

5.01

2.72

1.3

1.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

111

2.08

2.72

1.3

1.1

141.18

340.88

ng/l

0.47

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.24

2.72

1.1

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.24

2.72

1.1

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.24

2.72

1.1

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

115

844

1.37

2.72

1.8

1.7

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

6.01

2.70

1.0

1.2

313.00

252.00

nmol/l

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

381

1.56

2.69

2.2

1.8

28.89

24.88

ug/l

0.18

373

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.15

2.64

1.2

1.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

2.66

2.62

1.5

1.8

—

68.30

—

(3024869) Neuronal Ab [Presence] in Serum

2.66

2.62

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.16

2.60

2.8

2.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

4.67

2.59

1.1

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

223

1.71

2.53

2.5

16.14

6.47

umol/l

0.78

150

(3027035) Albumin [Mass/time] in 24 hour Urine

3.23

2.51

1.3

1.1

—

186.08

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

671

1.40

2.47

1.2

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

558

0.59

2.45

1.8

1.4

—

(3025130) Human papilloma virus identified in Specimen

218

1.70

2.44

2.0

1.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

196

1.74

2.42

1.2

—

(3006270) Folate [Moles/volume] in Blood

250

1.65

2.39

1.2

330.72

344.40

nmol/l

0.15

216

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

859

7836

1.12

2.36

1.9

1.6

1.54

1.33

mmol/l

4.52

723

6519

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

346

1.54

2.34

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.22

2.30

1.0

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

4.62

2.27

1.0

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

4.62

2.27

1.2

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

4.62

2.27

7.0

9.0

—

(3022621) pH of Urine by Test strip

227

1877

1.22

2.21

3.7

2.9

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.56

2.21

1.2

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

150

1.81

2.19

1.4

1.6

1.73

3.05

u/field

0.50

109

(3018133) Calcium [Moles/volume] in Urine

2.41

2.19

2.2

2.4

2.53

2.38

mmol/l

0.14

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

320

1.54

2.19

1.1

1.3

343.85

306.20

pmol/l

0.14

273

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

108

1.95

2.15

1.2

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

244

1.60

2.09

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

3.20

2.09

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

2.14

2.08

2.2

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

420

0.57

2.07

1.0

1.1

2.51

2.02

u/ml

0.11

244

(3020356) Listeria sp identified in Specimen by Organism specific culture

5.00

2.07

1.2

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

253

1.59

2.06

1.6

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.50

2.05

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

286

0.49

2.00

1.0

0.10

0.25

u/ml

—

107

(40768793) Breast Pathology biopsy report

488

1.40

1.93

1.4

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

334

0.54

1.92

1.0

1.1

6.23

4.14

u/ml

—

176

(3023323) Follitropin [Units/volume] in Serum or Plasma

105

808

1.31

1.91

1.6

1.5

23.40

27.02

iu/l

0.65

667

(3023511) Choriogonadotropin [Units/volume] in Urine

331

1.49

1.91

1.4

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

159

1.70

1.85

17.9

12.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

182

1.65

1.84

1.2

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

237

1.57

1.84

2.5

1.9

0.94

1.84

u/field

1.23

(4094501) Cardiovascular stress test using bicycle ergometer

834

0.71

1.84

1.0

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

3.53

1.83

1.2

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.09

1.75

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

163

1.66

1.71

2.4

2.0

105.45

147.82

ug/min

0.27

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.93

1.64

1.4

1.2

117.20

142.27

nmol/l

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

377

1.41

1.62

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2933

28699

1.10

1.62

5.3

4.7

6.32

5.98

mmol/l

17.51

2631

25826

(3036312) Salmon IgE Ab [Units/volume] in Serum

3.57

1.61

1.0

1.1

0.01

0.68

u/ml

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.50

1.59

1.3

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.50

1.59

2.3

1.7

—

(3019174) dRVVT (LA screen)

3.00

1.58

1.0

1.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.03

1.54

2.0

2.4

7.63

7.43

mmol/l

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.34

1.52

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.83

1.51

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

131

1.68

1.49

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

306

0.59

1.47

1.0

1.1

1.42

5.72

u/ml

—

138

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

109

1.75

1.46

3.1

1.8

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.37

1.45

1.4

2.4

14.19

20.20

umol/l

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.37

1.45

1.0

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

3.13

1.44

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1.92

1.43

3.5

4.1

6.87

7.97

mg/l

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

115

936

1.24

1.40

1.7

1.8

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

134

1.65

1.39

1.1

1.62

1.10

u/l

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

347

1.39

1.38

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

399

1.36

1.37

1.1

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

444

0.67

1.37

1.0

1.1

1.05

1.35

u/ml

0.18

219

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.61

1.36

1.2

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

751

1.26

1.36

2.8

2.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

374

1.37

1.35

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

735

1.26

1.34

1.6

1.7

308.23

304.94

mu/l

0.05

675

(3002079) Sodium [Moles/time] in 24 hour Urine

105

1.72

1.33

1.2

1.3

167.11

167.30

mmol/24h

0.00

105

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

376

1.36

1.32

3.5

1.9

25.29

20.14

mg/l

0.44

(44813793) Dust mix specific IgE antibody measurement

176

1.54

1.31

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

648

1.27

1.31

6.0

2.9

41.13

27.44

mg/l

1.90

398

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

353

0.65

1.27

1.2

1.3

8.17

7.38

mmol/l

0.45

298

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.05

1.26

1.7

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.63

1.21

1.8

4.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

377

1.33

1.15

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.05

1.15

1.5

1.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

505

0.73

1.12

1.2

1.1

4.04

2.88

u/ml

0.19

280

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.96

1.11

2.1

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.26

1.10

2.0

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

189

1659

1.15

1.05

1.3

73.86

58.51

au/ml

—

102

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

147

0.54

1.03

1.3

6.84

5.95

mmol/l

—

138

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

108

0.46

1.00

1.2

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.62

0.99

1.2

—

(3001729) Color of Synovial fluid

2.18

0.98

4.2

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

458

0.74

0.97

1.0

1.1

4.48

5.99

u/ml

0.29

262

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

301

1.33

0.97

1.6

1.7

—

(3022689) Creatine [Moles/volume] in Urine

1.69

0.95

1.6

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.78

0.94

1.5

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.89

0.94

1.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.22

0.93

1.0

1.1

7.83

10.59

u/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

119

1383

0.86

0.92

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

269

1.34

0.92

1.4

0.15

0.26

nmol/l

2.15

223

(1002224) Polysomnography panel

1016

0.83

0.92

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

278

1.33

0.91

3.7

3.0

118.22

27.55

mg/l

0.63

213

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.63

0.90

1.3

13.11

8.64

ug/l

1.03

(40768800) Prostate Pathology biopsy report

893

0.83

0.89

1.1

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.00

0.87

1.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.72

0.86

1.2

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

343

1.29

0.86

1.5

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

401

0.75

0.84

1.3

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

366

0.74

0.83

1.3

1.4

—

(3000285) Sodium [Moles/volume] in Blood

1.74

0.82

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

134

1177

1.14

0.79

1.8

1.9

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.82

0.79

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2813

27728

1.06

0.78

4.6

4.0

1.40

1.28

mmol/l

13.52

2558

25067

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

323

1.27

0.76

1.1

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.08

0.74

1.2

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.00

0.72

1.2

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

367

0.76

0.72

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

367

0.76

0.72

1.3

1.4

—

(4146454) Self-monitoring of blood glucose

353

1.25

0.71

2.4

2.7

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

366

0.76

0.70

1.3

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

1.51

0.69

2.4

2.7

28.29

30.75

umol/l

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.53

0.68

1.2

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

296

0.74

0.68

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

695

1.17

0.68

1.1

6.94

6.67

u/ml

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

136

1.40

0.66

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

312

1.25

0.66

1.1

1.3

—

nmol/l

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.53

0.66

1.0

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.79

0.66

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.79

0.66

1.6

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.54

0.65

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

304

0.76

0.64

1.3

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

378

1.22

0.62

1.1

—

8.34

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

104

1.44

0.62

2.3

2.1

28.80

99.49

ug/l

0.44

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

921

0.87

0.62

1.7

1.6

10.23

4.24

mg/l

1.10

662

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

748

7788

0.95

0.61

2.8

3.2

0.77

0.78

ug/l

0.11

515

5347

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

201

1847

1.09

0.59

2.4

42.88

23.12

au/ml

—

124

(3051101) Glucose [Moles/volume] in Cord blood

1.48

0.57

2.5

6.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1051

10830

0.96

0.55

4.2

4.5

22.64

21.94

0.62

484

5528

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

206

0.73

0.55

1.0

34.40

46.94

ng/l

—

130

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.58

0.54

1.7

1.0

—

(3005033) Fetal Nuchal fold Thickness US

295

0.78

0.54

1.3

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

205

0.73

0.54

1.0

588.40

678.65

ng/l

—

127

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1373

13405

1.04

0.52

5.1

5.2

7.19

3.27

ug/l

0.49

1210

11986

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.50

0.51

1.7

1.0

—

(3008898) HLA-B27 [Presence]

815

0.88

0.47

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.47

0.47

1.1

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

395

3763

1.06

0.46

5.2

4.6

32.24

32.53

0.20

306

2484

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.37

0.44

2.1

1.5

0.30

0.11

nmol/l

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

687

1.12

0.43

1.5

—

(3028717) Thiamine [Mass/volume] in Blood

1.56

0.42

1.0

1.3

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.7

—

12.15

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.40

0.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.39

0.38

13.4

7.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

325

3104

1.05

0.37

1.5

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

246

0.81

0.37

1.4

1.5

179.58

176.80

pmol/l

0.03

246

(3050129) First trimester maternal screen panel - Serum or Plasma

450

1.14

0.36

1.5

1.4

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.43

0.35

1.2

1.4

0.12

1.68

u/ml

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

162

1.24

0.35

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

126

1.27

0.35

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2980

29599

1.03

0.33

5.5

5.0

2.43

2.68

mmol/l

41.17

2715

27025

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

212

2233

0.95

0.32

1.3

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.35

0.32

1.6

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

404

3902

1.04

0.30

14.1

6.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.30

0.30

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

629

0.90

0.29

1.8

1.4

—

(3013637) Mi-2 Ab [Presence] in Serum

1.32

0.28

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.32

0.28

1.1

1.0

—

(3020650) Glucose [Presence] in Urine

1.32

0.28

1.9

1.6

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.32

0.28

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.32

0.28

1.1

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

285

2963

0.96

0.27

1.5

1.6

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

169

1.18

0.25

1.1

5.65

7.94

nmol/l

—

(1617658) Protocol used for examination of sentinel lymph nodes

161

1.18

0.24

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

192

1839

1.05

0.23

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.25

0.22

1.4

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

153

1602

0.95

0.22

1.2

112.46

146.76

iu/ml

0.54

573

(3015183) Erythrocyte sedimentation rate

124

0.81

0.21

4.5

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

132.67

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

623

1.08

0.21

1.5

1.8

6.72

4.73

iu/l

0.34

202

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2910

28956

1.02

0.21

5.0

4.5

4.27

4.54

mmol/l

34.66

2687

26602

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.0

—

3.58

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

132

1261

1.05

0.19

1.2

1.1

113.33

260.37

titre

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

218

2110

1.04

0.18

1.8

2.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

902

1.05

0.18

2.1

1.7

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.71

0.16

1.2

1.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

270

2636

1.03

0.14

2.5

2.1

10.24

12.80

nmol/l

5.33

225

2330

(3032773) Endomysium IgG Ab [Titer] in Serum

243

0.90

0.13

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

158

0.89

0.12

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

237

2318

1.02

0.12

1.9

2.1

—

(4034850) Laboratory test

966

0.96

0.12

14.8

9.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

279

1.08

0.11

1.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

216

1.07

0.06

2.7

1.5

120.61

82.63

umol/l

0.52

216

(3045683) HLA typing for celiac disease panel - Blood or Tissue

151

0.93

0.05

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

129

0.93

0.03

1.2

1.3

—

(3006462) Nitrate [Presence] in Urine

141

1.06

0.03

2.0

3.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

250

1.04

0.03

1.2

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

162

1.05

0.02

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

162

1.05

0.02

7.5

6.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

147

0.95

0.01

1.1

1.4

1.39

1.53

g/l

1.53

147

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

124

1.05

0.00

1.0

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2873

28721

1.00

0.00

4.9

4.4

1.34

1.43

mmol/l

21.07

2630

26212

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

185

1.03

0.00

2.6

1.5

2.70

3.55

ug/l

0.27

160

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

249

1.00

0.00

5.7

4.6

18.03

51.58

u/ml

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

343

0.99

0.00

1.1

5.54

2.02

u/ml

0.49

136

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

223

0.99

0.00

1.7

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.92

0.00

1.3

1.5

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3044336) Cobalt [Moles/volume] in Urine

0.00

-0.00

0.0

2.0

—

16.40

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

36.71

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.4

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

28.50

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.8

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.5

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

6.2

—

0.25

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.84

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

-0.00

0.0

2.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_STREPTO_SEPSIS and mortality.

Females

Parameter	HR [95% CI]	p-value
AB1_STREPTO_SEPSIS	2.884 [2.5, 3.33]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.19

During the follow-up period (1.1.1998 — 31.12.2019), 2934 out of 9755 females with AB1_STREPTO_SEPSIS died.

Males

Parameter	HR [95% CI]	p-value
AB1_STREPTO_SEPSIS	3.242 [2.81, 3.74]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 4143 out of 12444 males with AB1_STREPTO_SEPSIS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_STREPTO_SEPSIS.

N-year risk	Females	Males
1	0.266%	0.621%
5	1.546%	3.367%
10	3.906%	8.524%
15	7.522%	15.631%
20	13.365%	25.987%

Relationships between endpoints

↥

Index endpoint: AB1_STREPTO_SEPSIS – Streptococcal septicaemia

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Streptococcal septicaemia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints